Form 10-Q - Quarterly report [Sections 13 or 15(d)]

0.310.2920374920196331940001083220--12-312024Q1false002345211719795053P6YP4Y1M17DP4Y6MP25Y0001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberus-gaap:SubsequentEventMemberxelb:BusinessVentureAgreementMember2024-04-120001083220xelb:ImWhpLlcMemberxelb:BusinessVentureAgreementMember2022-05-310001083220xelb:BusinessVentureAgreementMember2022-05-310001083220xelb:ImTopcoMemberxelb:ServicesAgreementMember2023-11-012023-11-300001083220xelb:HalstonBrandMembersrt:MinimumMember2023-05-152023-05-150001083220xelb:HalstonBrandMembersrt:MaximumMember2023-05-152023-05-150001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-312022-05-3100010832202023-01-012023-12-310001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberus-gaap:SubsequentEventMemberxelb:BusinessVentureAgreementMember2024-04-122024-04-120001083220xelb:ImWhpLlcMemberxelb:BusinessVentureAgreementMember2022-05-312022-05-310001083220xelb:BusinessVentureAgreementMember2022-05-312022-05-310001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberxelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMemberus-gaap:SubsequentEventMember2024-04-122024-04-120001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-310001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberus-gaap:SubsequentEventMember2024-04-300001083220us-gaap:WarrantMember2023-01-012023-12-310001083220xelb:LoriGoldsteinBrandMember2021-04-012021-04-0100010832202024-02-162024-02-160001083220xelb:LoriGoldsteinBrandMember2024-01-012024-03-310001083220xelb:LoriGoldsteinBrandMember2023-01-012023-12-310001083220xelb:LoriGoldsteinBrandMember2022-01-012022-12-310001083220xelb:Lease1113BroadwayMember2024-01-262024-01-260001083220xelb:Lease530SeventhAvenueMember2024-02-292024-02-290001083220xelb:Lease1113BroadwayMember2024-01-012024-03-310001083220xelb:HalstonBrandMember2023-05-152023-05-150001083220xelb:HilcoGlobalMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberxelb:LongabergerLicensingLLCMember2024-01-012024-03-310001083220us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberxelb:LongabergerLicensingLLCMember2024-01-012024-03-310001083220xelb:ConsultantsMemberus-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001083220xelb:ConsultantsMember2023-01-012023-03-310001083220xelb:ConsultantsMemberus-gaap:CommonStockMember2024-01-012024-03-310001083220xelb:ConsultantsMemberus-gaap:CommonStockMember2023-01-012023-03-310001083220us-gaap:RetainedEarningsMember2024-03-310001083220us-gaap:NoncontrollingInterestMember2024-03-310001083220us-gaap:AdditionalPaidInCapitalMember2024-03-310001083220us-gaap:RetainedEarningsMember2023-12-310001083220us-gaap:NoncontrollingInterestMember2023-12-310001083220us-gaap:AdditionalPaidInCapitalMember2023-12-310001083220us-gaap:RetainedEarningsMember2023-03-310001083220us-gaap:NoncontrollingInterestMember2023-03-310001083220us-gaap:AdditionalPaidInCapitalMember2023-03-310001083220us-gaap:RetainedEarningsMember2022-12-310001083220us-gaap:NoncontrollingInterestMember2022-12-310001083220us-gaap:AdditionalPaidInCapitalMember2022-12-310001083220xelb:ConsultantsMemberus-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001083220xelb:ConsultantsMember2024-01-012024-03-310001083220us-gaap:CommonStockMember2024-03-310001083220us-gaap:CommonStockMember2023-12-310001083220us-gaap:CommonStockMember2023-03-310001083220us-gaap:CommonStockMember2022-12-310001083220us-gaap:PrivatePlacementMember2024-03-140001083220us-gaap:EmployeeStockOptionMember2023-01-012023-12-310001083220us-gaap:EmployeeStockOptionMember2023-12-310001083220us-gaap:EmployeeStockOptionMember2024-03-310001083220us-gaap:EmployeeStockOptionMember2023-12-310001083220xelb:HalstonBrandMemberus-gaap:WarrantMember2023-05-152023-05-150001083220xelb:ConsultantMember2024-01-122024-01-120001083220xelb:IMTopcoLLCMemberxelb:YearEndingDecember312025Memberus-gaap:SubsequentEventMember2024-04-120001083220xelb:IMTopcoLLCMemberxelb:TwelveMonthPeriodEndingMarch312025Memberus-gaap:SubsequentEventMember2024-04-120001083220xelb:ImTopcoMemberxelb:LicenseAgreementMember2023-03-310001083220srt:MaximumMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiSaleTransactionWithImTopcoMember2022-05-310001083220xelb:ImTopcoMemberxelb:LicenseAgreementMember2022-05-310001083220xelb:ImTopcoMemberxelb:ServicesAgreementMember2024-01-012024-03-310001083220xelb:ImTopcoMemberxelb:ServicesAgreementMember2023-01-012023-03-310001083220xelb:QurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-03-310001083220xelb:HalstonBrandMember2024-01-012024-03-310001083220us-gaap:LicenseMember2024-01-012024-03-310001083220xelb:QurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001083220us-gaap:ProductMember2023-01-012023-03-310001083220us-gaap:LicenseMember2023-01-012023-03-310001083220us-gaap:RetainedEarningsMember2024-01-012024-03-310001083220us-gaap:NoncontrollingInterestMember2024-01-012024-03-310001083220us-gaap:RetainedEarningsMember2023-01-012023-03-310001083220us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001083220xelb:PublicOfferingAndPrivatePlacementMember2024-03-152024-03-1500010832202024-03-012024-03-310001083220us-gaap:CommonStockMemberxelb:PublicOfferingAndPrivatePlacementMember2024-01-012024-03-310001083220us-gaap:AdditionalPaidInCapitalMemberxelb:PublicOfferingAndPrivatePlacementMember2024-01-012024-03-310001083220xelb:PublicOfferingAndPrivatePlacementMember2024-01-012024-03-310001083220us-gaap:PrivatePlacementMember2024-03-142024-03-140001083220xelb:PublicOfferingMember2024-03-192024-03-190001083220xelb:OrmeLiveMember2023-12-012023-12-310001083220xelb:ImTopcoMemberxelb:ServicesAgreementMember2022-05-310001083220us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-03-310001083220us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-03-310001083220xelb:ImTopcoMemberxelb:LicenseAgreementMember2023-11-012023-11-300001083220xelb:OrmeLiveMember2024-03-310001083220xelb:IMTopcoLLCMember2024-03-310001083220xelb:OrmeLiveMember2023-12-310001083220xelb:IMTopcoLLCMember2022-05-310001083220xelb:IMTopcoLLCMember2023-07-012023-09-300001083220xelb:OrmeLiveMember2024-01-012024-03-310001083220xelb:Lease1113BroadwayMemberxelb:RightOfUseAssetMember2024-02-292024-02-290001083220xelb:Lease1113BroadwayMemberus-gaap:LeaseholdImprovementsMember2024-01-012024-03-310001083220xelb:IMTopcoLLCMember2024-01-012024-03-310001083220xelb:IMTopcoLLCMember2023-01-012023-03-310001083220us-gaap:TrademarksMember2024-03-310001083220us-gaap:IntellectualPropertyMember2024-03-310001083220us-gaap:TrademarksMember2023-12-310001083220us-gaap:IntellectualPropertyMember2023-12-310001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberxelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMemberus-gaap:SubsequentEventMember2024-04-120001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberus-gaap:SubsequentEventMember2024-04-120001083220xelb:IMTopcoLLCMemberxelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMemberus-gaap:SubsequentEventMember2024-04-120001083220xelb:IMTopcoLLCMemberus-gaap:SubsequentEventMember2024-04-120001083220xelb:IMTopcoLLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember2024-03-310001083220xelb:IMTopcoLLCMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberxelb:IsaacMizrahiBrandTrademarksAndOtherIntellectualPropertyMember2022-05-270001083220us-gaap:RestrictedStockMember2024-01-012024-03-310001083220us-gaap:EmployeeStockOptionMember2024-03-310001083220us-gaap:SwapMember2023-10-190001083220xelb:IsraelDiscountBankOfNewYorkMemberus-gaap:SwapMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-10-190001083220xelb:HalstonBrandMember2024-03-310001083220xelb:HalstonBrandMember2023-12-310001083220xelb:NewLoanAndSecurityAgreementMember2023-10-192023-10-190001083220xelb:NewLoanAndSecurityAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-10-190001083220xelb:NewLoanAndSecurityAgreementMember2024-03-310001083220xelb:NewLoanAndSecurityAgreementMember2023-10-190001083220xelb:QurateRetailGroupMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-03-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-03-310001083220xelb:HalstonBrandMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2024-01-012024-03-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-12-310001083220xelb:QurateRetailGroupMemberus-gaap:SalesMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001083220xelb:PublicOfferingMember2024-03-190001083220xelb:PublicOfferingMember2024-03-150001083220us-gaap:CommonStockMemberxelb:PublicOfferingAndPrivatePlacementMember2024-03-310001083220us-gaap:RestrictedStockMember2024-03-310001083220srt:ExecutiveVicePresidentMemberxelb:PublicOfferingMember2024-03-190001083220srt:DirectorMemberxelb:PublicOfferingMember2024-03-190001083220srt:ChiefExecutiveOfficerMemberxelb:PublicOfferingMember2024-03-190001083220xelb:PublicOfferingAndPrivatePlacementMember2024-03-150001083220xelb:AgreementsMemberus-gaap:PrivatePlacementMember2024-03-140001083220srt:ExecutiveVicePresidentMemberus-gaap:PrivatePlacementMember2024-03-140001083220srt:DirectorMemberus-gaap:PrivatePlacementMember2024-03-140001083220srt:ChiefExecutiveOfficerMemberus-gaap:PrivatePlacementMember2024-03-140001083220us-gaap:RestrictedStockMember2023-12-310001083220xelb:UnexercisedStockOptionsMemberxelb:EquityIncentivePlan2021Member2024-03-310001083220xelb:UnexercisedStockOptionsMemberxelb:EquityIncentivePlan2011Member2024-03-310001083220xelb:EquityIncentivePlan2021Member2024-03-310001083220us-gaap:WarrantMember2024-03-310001083220us-gaap:WarrantMember2023-12-310001083220us-gaap:WarrantMember2024-03-190001083220xelb:HalstonBrandMemberus-gaap:WarrantMember2023-05-1500010832202022-12-3100010832202023-03-310001083220xelb:LoriGoldsteinBrandMember2023-12-310001083220us-gaap:WarrantMember2024-01-012024-03-310001083220us-gaap:EmployeeStockOptionMember2024-01-012024-03-310001083220us-gaap:WarrantMember2023-01-012023-03-310001083220us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001083220us-gaap:WarrantMember2024-01-012024-03-310001083220us-gaap:EmployeeStockOptionMember2024-01-012024-03-310001083220us-gaap:CommonStockMember2024-01-012024-03-310001083220us-gaap:WarrantMember2023-01-012023-03-310001083220us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001083220us-gaap:CommonStockMember2023-01-012023-03-310001083220us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001083220us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-3100010832202023-01-012023-03-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-03-310001083220xelb:QurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-12-3100010832202024-03-3100010832202023-12-3100010832202024-05-0100010832202024-01-012024-03-31xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purexelb:item

Table of Contents

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

​

FORM 10-Q

​

☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

​

For the quarterly period ended March 31, 2024

or

​

☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934

​

For the transition period from ___ to ___

​

Commission File Number: 001-37527

​

XCEL BRANDS, INC.

(Exact name of registrant as specified in its charter)

​

Delaware		76-0307819
(State or Other Jurisdiction of		(I.R.S. Employer
Incorporation or Organization)		Identification No.)

​

​

	550 Seventh Avenue, 11th Floor, New York, NY 10018
	(Address of Principal Executive Offices)

​

[phone]

(Issuer’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
Common Stock, $0.001 par value per share	​	XELB	​	NASDAQ Capital Market

​

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   ☒      No   ☐

​

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   ☒    No   ☐

​

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

​

​	​
Large accelerated filer ☐	Accelerated filer ☐
Non-accelerated filer ☒	Smaller reporting company   ☒
	Emerging growth company   ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

​

Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   ☐    No   ☒

​

As of May 1, 2024, there were 23,492,117 shares of common stock, $.001 par value per share, of the issuer outstanding.

​

​

​

​

Table of Contents

XCEL BRANDS, INC.

INDEX

​	a
​	​	Page
​	​	​
PART I - FINANCIAL INFORMATION		3
​	​	​
Item 1.	Financial Statements	3
​	​	​
​	Unaudited Condensed Consolidated Balance Sheets	3
​	​	​
​	Unaudited Condensed Consolidated Statements of Operations	4
​	​	​
​	Unaudited Condensed Consolidated Statements of Stockholders’ Equity	5
​	​	​
​	Unaudited Condensed Consolidated Statements of Cash Flows	6
​	​	​
​	Notes to Unaudited Condensed Consolidated Financial Statements	7
​	​	​
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
​	​	​
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	29
​	​	​
Item 4.	Controls and Procedures	30
​	​	​
PART II - OTHER INFORMATION		31
​	​	​
Item 1.	Legal Proceedings	31
​	​	​
Item 1A.	Risk Factors	31
​	​	​
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	31
​	​	​
Item 3.	Defaults Upon Senior Securities	31
​	​	​
Item 4.	Mine Safety Disclosures	32
​	​	​
Item 5.	Other Information	32
​	​	​
Item 6.	Exhibits	32
​	​	​
​	Signatures	32

​

​

2

Table of Contents

PART I. FINANCIAL INFORMATION

​

ITEM 1.    FINANCIAL STATEMENTS

​

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

​

​	​	​	​	​	​	​
​		March 31, 2024			December 31, 2023
​	​	(Unaudited)		​	(Note 1)
Assets		​			​
Current Assets:		​			​
Cash and cash equivalents	​	$	1,552	​	$	2,998
Accounts receivable, net of allowances for credit losses of $75 at March 31, 2024 and December 31, 2023	​		3,603	​		3,454
Inventory	​		445	​		453
Prepaid expenses and other current assets	​		471	​		398
Total current assets	​		6,071	​		7,303
Non-current Assets:	​	​	​	​	​	​
Property and equipment, net	​		133	​		634
Operating lease right-of-use assets	​	​	2,535	​	​	4,453
Trademarks and other intangibles, net	​		39,986	​		41,520
Equity method investment in IM Topco, LLC	​	​	17,070	​	​	17,585
Other assets	​		969	​		165
Total non-current assets	​		60,693	​		64,357
​	​	​	​	​	​	​
Total Assets	​	$	66,764	​	$	71,660
​	​	​	​	​	​	​
Liabilities and Stockholders' Equity	​			​
Current Liabilities:	​			​
Accounts payable, accrued expenses and other current liabilities	​	$	1,918	​	$	2,236
Deferred revenue	​		889	​		889
Accrued income taxes payable	​	​	372	​	​	372
Current portion of operating lease obligations	​	​	1,278	​	​	1,258
Current portion of long-term debt	​		1,000	​		750
Current portion of contingent obligation	​		723	​		964
Total current liabilities	​		6,180	​		6,469
Long-Term Liabilities:	​			​
Deferred revenue	​	​	3,333	​	​	3,556
Long-term portion of operating lease obligations	​	​	3,694	​	​	4,021
Long-term debt, net, less current portion	​		3,747	​		3,971
Long-term portion of contingent obligation	​	​	5,432	​	​	5,432
Other long-term liabilities	​		506	​		40
Total long-term liabilities	​		16,712	​		17,020
Total Liabilities	​		22,892	​		23,489
​	​	​	​	​	​	​
Commitments and Contingencies	​			​
​	​	​	​	​	​	​
Stockholders' Equity:	​			​
Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding	​		—	​		—
Common stock, $.001 par value, 50,000,000 shares authorized, and 23,452,117 and 19,795,053 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	​		23	​		20
Paid-in capital	​		105,904	​		103,861
Accumulated deficit	​		(60,143)	​		(53,849)
Total Xcel Brands, Inc. stockholders' equity	​		45,784	​		50,032
Noncontrolling interest	​	​	(1,912)	​	​	(1,861)
Total Stockholders' Equity	​		43,872	​		48,171
​	​	​	​	​	​	​
Total Liabilities and Stockholders' Equity	​	$	66,764	​	$	71,660

​

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

​

3

Table of Contents

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except share and per share data)

​

​	​	​	​	​	​	​
​	​	For the Three Months Ended
​	​	March 31,
​		2024			2023
Revenues	​	​			​
Net licensing revenue	​	$	2,184	​	$	2,222
Net sales	​		—	​		3,828
Net revenue	​		2,184	​		6,050
Cost of goods sold	​		—	​		2,693
Gross profit	​		2,184	​		3,357
​	​	​	​	​	​	​
Direct operating costs and expenses	​			​
Salaries, benefits and employment taxes	​		1,933	​		3,465
Other selling, general and administrative expenses	​		2,029	​		3,493
Total direct operating costs and expenses	​		3,962	​		6,958
​	​	​	​	​	​	​
Operating loss before other operating costs and expenses	​	​	(1,778)	​	​	(3,601)
​	​	​	​	​	​	​
Other operating costs and expenses	​	​	​	​	​	​
Depreciation and amortization	​		1,589	​		1,797
Asset impairment charges	​	​	2,295	​	​	—
Loss from equity method investments	​	​	533	​	​	515
​	​	​	​	​	​	​
Operating loss	​		(6,195)	​		(5,913)
​	​	​	​	​	​	​
Interest and finance (income) expense	​			​
Interest expense - term loan debt	​		146	​		—
Other interest and finance charges (income), net	​		4	​		25
Total interest and finance (income) expense	​		150	​		25
​	​	​	​	​	​	​
Loss before income taxes	​		(6,345)	​		(5,938)
​	​	​	​	​	​	​
Income tax benefit	​		—	​		—
​	​	​	​	​	​	​
Net loss	​	​	(6,345)	​	​	(5,938)
Net loss attributable to noncontrolling interest	​	​	(51)	​	​	(295)
Net loss attributable to Xcel Brands, Inc. stockholders	​	$	(6,294)	​	$	(5,643)
​	​	​	​	​	​	​
Loss per common share attributable to Xcel Brands, Inc. stockholders:	​			​
Basic and diluted net loss per share	​	$	(0.31)	​	$	(0.29)
Weighted average number of common shares outstanding:	​			​
Basic and diluted weighted average common shares outstanding	​		20,374,920	​		19,633,194

​

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

​

4

Table of Contents

​

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share data)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Xcel Brands, Inc. Stockholders

​

​

​

​

​

​

​

​

​

Common Stock

​

​

​

​

​

​

​

​

​

​

​

​

​

Number of

​

​

​

​

Paid-In

​

Accumulated

​

Noncontrolling

​

​

​

​

Shares

Amount

Capital

Deficit

Interest

​

​

Total

Balance as of December 31, 2022

19,624,860

​

$

20

​

$

103,592

​

$

(32,797)

​

$

(676)

​

​

$

70,139

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Compensation expense related to stock options and restricted stock

​

—

​

​

—

​

​

51

​

​

—

​

​

—

​

​

​

51

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued to consultant in connection with stock grant

​

8,334

​

​

—

​

​

6

​

​

—

​

​

—

​

​

​

6

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net loss

—

​

—

​

—

​

(5,643)

​

​

(295)

​

​

(5,938)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance as of March 31, 2023

19,633,194

​

$

20

​

$

103,649

​

$

(38,440)

​

$

(971)

​

​

$

64,258

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance as of December 31, 2023

19,795,053

​

$

20

​

$

103,861

​

$

(53,849)

​

$

(1,861)

​

​

$

48,171

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Compensation expense related to stock options and restricted stock

​

—

​

​

—

​

​

36

​

​

—

​

​

—

​

​

​

36

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Contra-revenue related to warrants held by licensee

​

—

​

​

—

​

​

10

​

​

—

​

​

—

​

​

​

10

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued to consultant in connection with stock grant

78,000

​

—

​

98

​

—

​

—

​

​

98

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued in connection with public offering and private placement transactions, net of transaction costs

​

3,579,064

​

​

3

​

​

1,899

​

​

—

​

​

—

​

​

​

1,902

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net loss

—

​

—

​

—

​

(6,294)

​

​

(51)

​

​

(6,345)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance as of March 31, 2024

23,452,117

​

$

23

​

$

105,904

​

$

(60,143)

​

$

(1,912)

​

​

$

43,872

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

​

5

Table of Contents

​

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

​

​	​	​	​	​	​	​
​	​	For the Three Months Ended March 31,
​		2024			2023
Cash flows from operating activities		​			​
Net loss	​	$	(6,345)	​	$	(5,938)
Adjustments to reconcile net loss to net cash used in operating activities:	​		​	​
Depreciation and amortization expense	​		1,589	​		1,797
Asset impairment charges	​		2,295	​		—
Amortization of deferred finance costs included in interest expense	​		26	​		—
Stock-based compensation and cost of licensee warrants	​		144	​		57
Undistributed proportional share of net loss of equity method investees	​	​	533	​	​	515
Changes in operating assets and liabilities:	​		​	​		​
Accounts receivable	​		(149)	​		(859)
Inventory	​		8	​		(254)
Prepaid expenses and other current and non-current assets	​		(156)	​		425
Deferred revenue	​	​	(223)	​	​	240
Accounts payable, accrued expenses, accrued income taxes payable, and other current liabilities	​		(560)	​		1,156
Lease-related assets and liabilities	​	​	(237)	​	​	(54)
Other long-term liabilities	​		466	​		—
Net cash used in operating activities	​		(2,609)	​		(2,915)
​	​	​	​	​	​	​
Cash flows from investing activities	​			​
Purchase of property and equipment	​		—	​		(81)
Net cash used in investing activities	​		—	​		(81)
​	​	​	​	​	​	​
Cash flows from financing activities	​			​
Proceeds from public offering and private placement transactions, net of transaction costs	​	​	1,902	​	​	—
Net cash provided by financing activities	​		1,902	​		—
​	​	​	​	​	​	​
Net decrease in cash, cash equivalents, and restricted cash	​		(707)	​		(2,996)
​	​	​	​	​	​	​
Cash, cash equivalents, and restricted cash at beginning of period	​	​	2,998	​	​	4,608
​	​	​	​	​	​	​
Cash, cash equivalents, and restricted cash at end of period	​	$	2,291	​	$	1,612
​	​	​	​	​	​	​
Reconciliation to amounts on consolidated balance sheets:	​			​
Cash and cash equivalents	​	$	1,552	​	$	1,612
Restricted cash (reported in other non-current assets)	​		739	​		—
Total cash, cash equivalents, and restricted cash	​	$	2,291	​	$	1,612
​	​	​	​	​	​	​
Supplemental disclosure of cash flow information:	​			​
Cash paid during the period for interest	​	$	119	​	$	—
Cash paid during the period for income taxes	​	$	—	​	$	16

​

​

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

​

​

6

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

1. Nature of Operations, Background, and Basis of Presentation

The accompanying condensed consolidated balance sheet as of December 31, 2023 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on April 19, 2024.

The Company is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands.

Currently, the Company’s brand portfolio consists of the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), the TowerHill by Christie Brinkley brand (the “CB Brand”), and other proprietary brands.

●

The Halston Brand, Ripka Brand, C Wonder Brand, and Lori Goldstein Brand are wholly owned by the Company.

●

The Company manages the Longaberger Brand through its 50% ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party.

●

The Company holds a noncontrolling interest in the Isaac Mizrahi Brand through its 30% ownership interest in IM Topco, LLC; the Company accounts for its interest in IM Topco, LLC using the equity method of accounting.

●

The CB Brand is a new co-branded collaboration between Xcel and Christie Brinkley, announced in 2023 and planned to launch by the end of May 2024.

The Company also owns a 30% interest in ORME Live, Inc. (“ORME”), a short-form video and social commerce marketplace that is planned to launch in 2024.

The Company primarily generates revenue through the licensing of its brands through contractual arrangements with manufacturers and retailers. The Company, through its licensees, distributes through an omni-channel and social commerce sales strategy, which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop.

7

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

Prior to and for a portion of 2023, the Company also engaged in wholesale and direct-to-consumer sales of products under its brands. The Company’s former wholesale and direct-to-consumer operations were presented as "Net sales" and "Cost of goods sold" in the condensed consolidated statements of operations, separately from the Company’s licensing revenues.

Liquidity and Management’s Plans  

The Company incurred a net loss attributable to Company stockholders of approximately $6.3 million during the three months ended March 31, 2024 (which included non-cash expenses of approximately $4.6 million), and had an accumulated deficit of approximately $60.1 million as of March 31, 2024. Net cash used in operating activities was approximately $2.6 million for the three months ended March 31, 2024. The Company had working capital (current assets less current liabilities, excluding the current portions of lease obligations, deferred revenue, and any contingent obligations payable in common stock) of approximately $2.1 million as of March 31, 2024. The Company’s unrestricted cash and cash equivalents were approximately $1.6 million as of March 31, 2024. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern.

​

During the year ended December 31, 2023, management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting its business from a wholesale/licensing hybrid model into a “licensing plus” model. To affect this transition, the Company entered into various new licensing agreements and joint venture arrangements with best-in-class business partners. These restructuring initiatives were substantially completed as of June 30, 2023. Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of December 31, 2023, the Company had reduced payroll costs by approximately $6 million and operating expenses (excluding non-recurring charges related to the restructuring) by approximately $9 million, on an annualized basis when compared to the corresponding periods in the prior year.

Also during the year ended December 31, 2023, the Company entered into a new term loan agreement in the amount of $5 million, which provided the Company with additional liquidity.

Further, in March 2024, the Company issued new shares of common stock for net proceeds of approximately $1.9 million, which provided the Company with additional liquidity.

Based on the aforementioned events and changes, management expects that existing cash and future operating cash flows will be adequate to meet the Company’s operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q; therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of March 31, 2024, have been alleviated.

​

​

2.      Investments in Unconsolidated Affiliates and Variable Interest Entities  

Investment in IM Topco, LLC

On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold 70% of the membership interests of IM Topco to WHP.

8

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

The Company accounts for its 30% interest in the ongoing operations of IM Topco as other operating costs and expenses under the equity method of accounting. Pursuant to the business venture agreement between the Company and WHP governing the operation of IM Topco, IM Topco’s net cash flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows:

(i)

first, 100% to WHP, until WHP has received an aggregate amount during such fiscal year equal to $8,852,000 (subject to adjustment in certain circumstances as set forth in the agreement);

(ii)

second, 100% to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to $1,316,200 (subject to adjustment in certain circumstances as set forth in the agreement); and

(iii)

thereafter, in proportion to the members’ respective percentage interests.

Based on these distribution provisions, the Company recognized an equity method loss of $0.52 million related to its investment in IM Topco for each of the three-month periods ended March 31, 2024 and 2023. For cash flow earnings (i.e., net income before intangible asset amortization expense), management allocated the amounts based on the preferences outlined above. As such, Xcel recognized no cash-based earnings for both of the periods presented. For non-cash amortization expense, management allocated the amounts based on the relative ownership of each member (i.e., 70% WHP and 30% Xcel). The equity method loss for each period presented is equal Xcel’s share of amortization expense.

Summarized financial information for IM Topco for the three months ended March 31, 2024 and 2023 is as follows:

​	​	​	​	​	​	​
​		For the three months ended
​	​	March 31,
($ in thousands)	​	2024		​	2023
Revenues	​	$	2,752	​	$	3,346
Gross profit	​	​	2,752	​	​	3,346
Loss from continuing operations	​	​	(437)	​	​	(143)
Net loss	​	​	(437)	​	​	(143)

​

Refer to Notes 10, 11, and 12 for other information regarding the Company’s ongoing relationship with IM Topco.

​

Investment in Orme Live, Inc.

In December 2023, the Company contributed $0.15 million of cash to ORME in exchange for a 30% equity ownership interest in ORME. The carrying value of this investment is included within other assets in the Company’s condensed consolidated balance sheets.

The Company accounts for its 30% interest in the operations of ORME as a component of other operating costs and expenses under the equity method of accounting. The Company’s proportional share of the operating results of ORME for the three months ended March 31, 2024 was a loss of approximately $0.02 million.

9

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

Longaberger Licensing, LLC Variable Interest Entity

Since 2019, Xcel has been party to a limited liability company agreement with a subsidiary of Hilco Global related to Longaberger Licensing, LLC (“LL”). Hilco Global is the sole Class A Member of LL, and Xcel is the sole Class B Member of LL (each individually a “Member”). Each Member holds a 50% equity ownership interest in LL; however, based on an analysis of the contractual terms and rights contained in the LLC agreement and related agreements, the Company has previously determined that under the applicable accounting standards, LL is a variable interest entity and the Company has effective control over LL. Therefore, as the primary beneficiary, the Company has consolidated LL since 2019, and has recognized the assets, liabilities, revenues, and expenses of LL as part of its consolidated financial statements, along with a noncontrolling interest which represents Hilco Global’s 50% ownership share in LL.

​

​

3.      Trademarks and Other Intangibles  

Trademarks and other intangibles, net consist of the following:

​

​	​	​	​	​	​	​	​	​	​	​	​
​		Weighted		​	​		​	​		​	​
​		Average		March 31, 2024
​		Amortization	​	Gross Carrying		​	Accumulated		​	Net Carrying
($ in thousands)	​	Period	​	Amount		​	Amortization		​	Amount
Trademarks (finite-lived)		15 years	​		68,880	​		28,950	​		39,930
Copyrights and other intellectual property		8 years	​		429	​		373	​		56
Total	​	​	​	$	69,309	​	$	29,323	​	$	39,986

​

​	​	​	​	​	​	​	​	​	​	​	​
​		Weighted		​	​		​	​		​	​
​		Average		December 31, 2023
​		Amortization		Gross Carrying		​	Accumulated		​	Net Carrying
($ in thousands)	​	Period	​	Amount		​	Amortization		​	Amount
Trademarks (finite-lived)		15 years	​		68,880	​		27,431	​		41,449
Copyrights and other intellectual property		8 years	​		429	​		358	​		71
Total			​	$	69,309	​	$	27,789	​	$	41,520

​

Amortization expense for intangible assets was approximately $1.53 million for the three-month period ended March 31, 2024 (the "current quarter") and approximately $1.54 million for the three-month period ended March 31, 2023 (the "prior year quarter").

​

4.      Significant Contracts and Concentrations

Qurate Agreements

Under the Company’s agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based primarily upon a percentage of net retail sales of certain specified branded merchandise. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes. Net licensing revenue from the Qurate Agreements represents a significant portion of the Company’s total net revenue.

Net licensing revenue from the Qurate Agreements totaled $1.61 million and $1.52 million for the current quarter and prior year quarter, respectively, representing approximately 59% and 25% of the Company’s total net revenue for the current quarter and prior year quarter, respectively.

10

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

As of March 31, 2024 and December 31, 2023, the Company had receivables from Qurate of $1.3 million and $1.5 million, respectively, representing approximately 37% and 43% of the Company’s total net accounts receivable, respectively.

​

Halston Master License

On May 15, 2023, the Company, through its wholly owned subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with G-III Apparel Group (“G-III”), an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provided for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to G-III’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. G-III has an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted G-III a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option.

As a result of the upfront cash payment and guaranteed minimum royalties discussed above, the Company has recognized $4.2 million and $4.4 million of deferred revenue contract liabilities on its condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023, respectively. As of December 31, 2023, $0.9 million of the contract liability balance was classified as a current liability and approximately $3.5 million was classified as a long-term liability. As of March 31, 2024, $0.9 million of the contract liability balance was classified as a current liability and approximately $3.3 million was classified as a long-term liability.

The balance of the deferred revenue contract liabilities will be recognized ratably as revenue over the next 4.13 years. Net licensing revenue recognized from the Halston Master License was $0.6 million for the current quarter, representing approximately 30% of the Company’s total net revenue for the current quarter.

​

5. Leases

The Company is party to operating leases for real estate, and for certain equipment with a term of 12 months or less. The Company is currently not a party to any finance leases.

Lease expense (net of sublease income) included in selling, general and administrative expenses on the Company’s condensed consolidated statements of operations was approximately $0.2 million and $0.4 million for the current quarter and prior year quarter, respectively. Cash paid for amounts included in the measurement of operating lease liabilities was approximately $0.4 million in both the current quarter and prior year quarter.

1333 Broadway

The Company has an operating lease for offices located at 1333 Broadway, 10th floor, New York, New York, which commenced on March 1, 2016 and expires on October 30, 2027. The average annual fixed rent over the term of this lease is approximately $1.3 million per year, and the lease requires the Company to pay additional rents related to increases in certain taxes and other costs on the property.

11

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

On January 26, 2024, the Company (as sublessor) entered into an agreement for the sublease of the offices located at 1333 Broadway to a third-party subtenant through October 30, 2027. The average annual fixed rent over the term of the sublease is approximately $0.8 million per year. As a result of entering into the sublease, the Company recognized a non-cash impairment charge of approximately $1.9 million effective February 29, 2024 (which was determined to be the date of a fundamental change to the use of the 1333 Broadway premises) related to the right-of-use asset. Also in connection with entering into the sublease, the Company recognized a non-cash impairment charge of approximately $0.4 million during the current quarter related to leasehold improvement assets at this location.

As of March 31, 2024, the Company’s lease of 1333 Broadway has a remaining lease term of approximately 3.58 years, and the lease liability recorded on the Company’s condensed consolidated balance sheet is measured using a discount rate of 6.25%.

550 Seventh Avenue

Effective February 29, 2024, the Company entered into an operating lease for new corporate offices located at 550 Seventh Avenue, 11th floor, New York, New York. This lease commenced in April 2024 and expires in April 2031. The average annual lease cost over the term of this lease is approximately $0.5 million per year. As of March 31, 2024, no right-of-use asset or lease liability was recorded in the Company’s condensed consolidated balance sheet related to this lease, as the lease had not yet commenced.

Future Lease Obligations

As of March 31, 2024, the maturities of lease obligations were as follows:

​

​	​	​	​
​	​	Amount
Year		(in thousands)
2024 (April 1 through December 31)	​	$	1,164
2025	​	​	1,552
2026	​		1,552
2027	​		1,294
Total lease payments	​	​	5,562
Less: Discount	​	​	590
Present value of lease liabilities	​	​	4,972
Current portion of lease liabilities	​	​	1,278
Non-current portion of lease liabilities	​	$	3,694

​

​

​

​

6. Debt

The Company’s net carrying amount of debt was comprised of the following:

​

​	​	​	​	​	​	​	​
​	​	March 31,		​	December 31,		​
($ in thousands)		2024			2023		​
Term loan debt	​	$	5,000	​	$	5,000	​
Unamortized deferred finance costs related to term loan debt	​		(253)	​		(279)	​
Total	​		4,747	​		4,721	​
Current portion of debt	​		1,000	​		750	​
Long-term debt	​	$	3,747	​	$	3,971	​

​

12

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

On October 19, 2023, H Halston IP, LLC (the “Borrower”), a wholly owned indirect subsidiary of Xcel Brands, Inc., entered into a term loan agreement with Israel Discount Bank of New York (“IDB”). Pursuant to this loan agreement, IDB made a term loan to the Company in the aggregate amount of $5.0 million. The proceeds of this term loan were used to pay fees, costs, and expenses incurred in connection with entering into the loan agreement, and may be used for working capital purposes. Such costs incurred in connection with the borrowing included a commitment fee paid to IDB, plus various legal and other fees. These fees and costs totaling $0.3 million have been deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt, and are being amortized to interest expense over the term of the debt using the effective interest method.

​

In connection with this term loan agreement, the Borrower and H Licensing, LLC (“H Licensing”), a wholly owned subsidiary of Xcel, entered into a security agreement (the “Security Agreement”) in favor of IDB, and Xcel entered into a Membership Interest Pledge Agreement (the “Pledge Agreement”) in favor of IDB. Pursuant to the Security Agreement, the Borrower and H Licensing granted to IDB a security interest in substantially all of their respective assets, other than the trademarks owned by the Borrower and H Licensing, to secure the Borrower’s obligations under the October 2023 loan agreement.  Pursuant to the Pledge Agreement, Xcel granted to IDB a security interest in its membership interests in H Licensing to secure the Borrower’s obligations under the October 2023 loan agreement.

​

The term loan matures on October 19, 2028. Principal on the term loan is payable in quarterly installments of $250,000 on each of January 2, April 1, July 1, and October 1 of each year, commencing on April 1, 2024. The Borrower has the right to prepay all or any portion of the term loan at any time without penalty.

​

As of March 31, 2024, the aggregate remaining principal payments under the term loan were as follows:

​

​	​	​	​
​	​	Amount of
($ in thousands)		Principal
Year Ending December 31,		Payment
2024 (April 1 through December 31)	​	$	750
2025	​		1,000
2026	​	​	1,000
2027	​	​	1,000
2028	​		1,250
Total	​	$	5,000

​

Interest on the term loan accrues at “Term SOFR” (as defined in the loan agreement as the forward-looking term rate based on secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to one month on the day that is two U.S. Government Securities Business Days prior to the first day of each calendar month) plus 4.25% per annum. Interest on the term loan is payable on the first day of each calendar month. In addition, on October 19, 2023, the Borrower also entered into a swap agreement with IDB, pursuant to which IDB will pay the Borrower Term SOFR plus 4.25% per annum on the notional amount of the swap in exchange for the Borrower paying IDB 9.46% per annum on such notional amount. The term and declining notional amount of the swap agreement is aligned with the amortization of the October 2023 term loan principal amount. The fair value of this swap agreement was immaterial as of March 31, 2024 and December 31, 2023.

​

For the current quarter, the Company incurred interest expense (including both interest paid in cash and the amortization of deferred finance costs) related to term loan debt of approximately $0.15 million, reflecting an effective interest rate of approximately 11.6%.

The term loan agreement also contains customary covenants, including reporting requirements, trademark preservation, and certain financial covenants including annual guaranteed minimum royalty ratio, annual fixed charge coverage ratio,

13

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

and minimum cash balance levels, all as specified and defined in the loan agreement. The Company was in compliance with all applicable covenants under the loan agreement as of and for all periods presented in the financial statements.

​

7. Stockholders’ Equity

Public Offering and Private Placement Transactions

On March 15, 2024, the Company entered into an underwriting agreement with Craig-Hallum Capital Group LLC (the “Representative”), as the representative of the underwriters, relating to a firm commitment underwritten public offering (the “Offering”) of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share.

The closing of the Offering occurred on March 19, 2024. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company, were approximately $1.7 million.

Upon closing of the Offering, the Company issued the Representative certain warrants to purchase up to 182,952 shares of common stock (the “Representative’s Warrants”) as compensation, which amount was offset against the proceeds received. The Representative’s Warrants will be exercisable at a per share exercise price of $0.8125. The Representative’s Warrants are exercisable, in whole or in part, during the four and one-half-year period commencing 180 days from the commencement of sales of the shares of common stock in the Offering.

In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering.

The aggregate number of shares of common stock issued from the Offering and the Private Placement was 3,579,064 shares and the total net proceeds received was approximately $1.9 million.

Equity Incentive Plans

A total of 4,000,000 shares of common stock are eligible for issuance under the Company’s 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board.

In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.

Stock-based Compensation

The Company accounts for stock-based compensation by recognizing the fair value of such compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable. Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur. For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense

14

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable.

Total expense recognized for all forms of stock-based compensation was approximately $0.13 million and $0.06 million for the current quarter and prior year quarter, respectively. For both periods, substantially all of the expense was related to directors and consultants, and was recorded as operating costs within “other selling, general and administrative expenses” in the accompanying condensed consolidated statements of operations.

Stock Options

A summary of the Company’s stock options activity for the current quarter is as follows:

​

​	​	​	​	​	​	​	​	​	​	​
​	​	​	​	​	​	​	Weighted	​	​	​
​	​	​	​	​	​	​	Average	​	​	​
​	​	​	​	Weighted		​	Remaining	​	​	​
​	​	​	​	Average		​	Contractual	​	Aggregate
​	​	Number of	​	Exercise		​	Life	​	Intrinsic
​		Options		Price			(in Years)		Value
Outstanding at January 1, 2024		5,148,540	​	$	2.03		4.26	​	$	—
Granted		—	​		—			​
Exercised		—	​		—			​
Expired/Forfeited		(259,500)	​		4.21			​
Outstanding at March 31, 2024, and expected to vest		4,889,040	​	$	1.91		4.24	​	$	—
Exercisable at March 31, 2024		1,139,040	​	$	2.58		1.78	​	$	—

​

Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $0.02 million and $0.03 million, respectively. Total unrecognized compensation expense related to unvested stock options at March 31, 2024 was approximately $0.05 million and is expected to be recognized over a weighted average period of approximately 0.97 years.

A summary of the Company’s non-vested stock options activity for the current quarter is as follows:

​

​	​	​	​	​	​
​		​		Weighted
​	​	​	​	Average
​	​	Number of	​	Grant Date
​		Options		Fair Value
Balance at January 1, 2024		3,750,000	​	$	0.05
Granted		—	​		—
Vested		—	​	​	—
Forfeited or Canceled		—	​		—
Balance at March 31, 2024		3,750,000	​	$	0.05

​

​

15

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

Stock Awards

A summary of the Company’s restricted stock activity for the current quarter is as follows:  

​

​	​	​	​	​	​
​	​	​	​	Weighted
​	​	Number of	​	Average
​	​	Restricted	​	Grant Date
​		Shares		Fair Value
Outstanding at January 1, 2024		333,333	​	$	3.69
Granted		78,000	​		1.25
Vested		(78,000)	​		1.25
Expired/Forfeited		—	​		—
Outstanding at March 31, 2024		333,333	​	$	3.69

​

On January 12, 2024, the Company issued 78,000 shares of common stock to a consultant, which shares vested immediately.

Compensation expense related to stock awards was approximately $0.11 million for the current quarter and approximately $0.03 million for the prior year quarter. Total unrecognized compensation expense related to unvested restricted stock grants at March 31, 2024 was approximately $0.04 million and is expected to be recognized over a weighted average period of approximately 0.96 years.

Restricted Stock Units

There were no restricted stock units outstanding as of March 31, 2024 and December 31, 2023, and no restricted stock units have been issued since the inception of the 2021 Plan.

Shares Available Under the Company’s Equity Incentive Plans

At March 31, 2024, there were 3,025,941 shares of common stock available for future award grants under the 2021 Plan.

Shares Reserved for Issuance

As of March 31, 2024, there were 8,031,046 shares of common stock reserved for issuance, including 4,511,755 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 493,350 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 3,025,941 shares available for issuance under the 2021 Plan.

​

​

16

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

Warrants

A summary of the Company’s warrants activity for the current quarter is as follows:

​

​	​	​	​	​	​	​	​	​	​	​
​	​	​	​	​	​	​	Weighted	​	​	​
​	​	​	​	​	​	​	Average	​	​	​
​	​	​	​	Weighted		​	Remaining	​	​	​
​	​	​		Average			Contractual	​	Aggregate
​	​	Number of	​	Exercise			Life	​	Intrinsic
​		Warrants		Price			(in Years)		Value
Outstanding and exercisable at January 1, 2024		1,116,065	​	$	1.67		8.46	​	$	—
Issued		182,952	​		0.81		​	​
Exercised		—	​		—		​	​
Expired/Forfeited		—	​		—		​	​
Outstanding at March 31, 2024		1,299,017	​	$	1.55		7.75	​	$	—
Exercisable at March 31, 2024		116,065	​	$	3.15		0.30	​	$	—

​

Warrants issued during the current quarter were related to the March 19, 2024 Offering (see “Public Offering and Private Placement Transactions” above for details). There was no compensation expense recognized during the current quarter related to these warrants.

In connection with the entrance into the Halston Master License (see Note 4), the Company issued to G-III a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vests based upon certain annual royalty targets being satisfied under the license agreement. The fair value of this warrant is being recognized as a reduction of revenue over the term of the related license agreement, with an offsetting increase to stockholders’ equity as additional paid-in capital. The amount of contra-revenue recorded related to this warrant during the current quarter was approximately $0.01 million. As of March 31, 2024, no portion of this warrant had vested.

Excluding the contra-revenue recognized with respect to the Halston Master License warrant, there was no compensation expense related to warrants recognized in the current quarter or prior year quarter.

​

8.    Earnings (Loss) Per Share

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS reflects, in periods in which they have a dilutive effect, the effect of common shares issuable upon the exercise of stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive.

​

17

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

The following table is a reconciliation of the numerator and denominator of the basic and diluted net loss per share computations for the three months ended March 31, 2024 and 2023:

​

​	​	​	​	​	​	​	​
​	​	​	Three Months Ended				​
​	​	March 31,					​
​		2024			2023		​
Numerator:	​	​	​	​	​	​	​
Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)	​	$	(6,294)	​	$	(5,643)	​
​	​	​	​	​	​	​	​
Denominator:	​	​	​	​	​	​	​
Basic weighted average number of shares outstanding	​	​	20,374,920		​	19,633,194
Add: Effect of warrants	​	​	—		​	—
Add: Effect of stock options	​	​	—	​	​	—	​
Diluted weighted average number of shares outstanding	​	​	20,374,920		​	19,633,194	​
​	​	​	​	​	​	​	​
Basic net loss per share	​	$	(0.31)	​	$	(0.29)	​
Diluted net loss per share	​	$	(0.31)	​	$	(0.29)	​

​

As a result of the net loss for the current quarter and prior year quarter, the Company calculated diluted EPS using basic weighted average shares outstanding for such periods, as utilizing diluted shares would be anti-dilutive to loss per share for such periods.

​

The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:  

​

​	​	​	​	​	​
​	​	Three Months Ended			​
​	​	March 31,			​
​		2024		2023	​
Stock options	​	4,889,040	​	5,368,780	​
Warrants	​	1,299,017	​	116,065	​
Total	​	6,188,057		5,484,845

​

​

9.    Income Taxes

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% for both periods, resulting in an income tax benefit of $0 for both periods.

For both the current quarter and the prior year quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

​

​

18

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

10.    Related Party Transactions

IM Topco, LLC

As described in Note 2, the Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting.

Service Agreement

On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business and related talent support) to IM Topco in exchange for payments of $300,000 per year.

​

In November 2023, the services agreement was amended such that the Company agreed to provide IM Topco with a $600,000 reduction of future service fees over the next eighteen months, beginning on July 1, 2023.

​

The Company recognized service fee income related to this agreement of $37,500 and $75,000 for the current quarter and prior year quarter, respectively.

​

License Agreement

​

On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed minimum royalties to IM Topco of $400,000 per year.

​

Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the prior year quarter, the estimated amount of such shortfall was approximately $60,000, which the Company recognized as royalty expense in the condensed consolidated statements of operations.

​

In November 2023, the Company, WHP, and IM Topco entered into an amendment of the May 27, 2022 membership purchase agreement, under which Xcel agreed to make additional royalty payments to IM Topco totaling $450,000 over the next 11 months. As a result of this amendment, the Company recognized a $450,000 increase to the carrying value basis of its equity method investment in IM Topco and a corresponding increase in current liabilities. No amounts were paid to IM Topco during the current quarter, and as of March 31, 2024, the remaining payments due totaled $375,000.

​

Financing Transactions

​

Public Offering and Private Placement Transactions

​

In connection with the Offering of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share which was consummated on March 19, 2024 (see Note 7 for additional details), Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company, purchased 146,250, 146,250, and

19

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

32,500 shares, respectively, at $0.65 per share, the same price at which the shares were sold to other purchasers in the Offering.

In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Mr. D’Loren, Mr. DiSanto, and Mr. Burroughs to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering.

​

11.    Commitments and Contingencies

Contingent Obligation – Isaac Mizrahi Transaction

In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand, the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP would be entitled to receive from Xcel up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. In November 2023, this agreement was amended such that the purchase price adjustment provision was waived until the measurement period ending March 31, 2024. The purchase price adjustment provision was subsequently further amended in April 2024 (see Note 12 for details).

No amount has been recorded in the accompanying condensed consolidated balance sheets related to this contingent obligation.

Contingent Obligation – Lori Goldstein Earn-Out

In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid, in accordance with the guidance in ASC Subtopic 805-50.

As of December 31, 2022, based on the performance of the Lori Goldstein brand to date, approximately $0.2 million of additional consideration was earned by the seller, and this $0.2 million of additional consideration was paid to the seller during 2023.

Based on the performance of the Lori Goldstein through December 31, 2023, approximately $1.0 million of incremental additional consideration was earned by the seller, which will be paid out in 2024. During the current quarter, the Company paid approximately $0.3 million of the $1.0 million earned, and as of March 31, 2024, $0.7 million of the remaining balance was recorded as a current liability and $5.4 million was recorded as a long-term liability.

Legal Matters

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

​

20

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

March 31, 2024

(Unaudited)

With the exception of the matter described in detail below, in the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows.

​

On February 16, 2024, counsel to Lori Goldstein, a brand spokesperson for the Company, advised the Company that the Company was in material breach of the Asset Purchase Agreement dated March 31, 2021 (the “Asset Purchase Agreement”) by and among Gold Licensing LLC (“Gold” and, together with Xcel, the ”Xcel Parties”), a subsidiary of the Company, and Lori Goldstein and Lori Goldstein, Ltd. (“LG Ltd” and, together with Lori Goldstein, the “LG Parties”) for failure to pay $963,642 earned in 2023 in accordance with the earn-out provisions of the agreement. The Company does not dispute the amount of the Lori Goldstein Earn-Out that was achieved in 2023, and advised Ms. Goldstein that due to the alleged breaches described below, the Company was not willing to pay this amount at such time. The Company subsequently paid approximately $241,000 of the earn-out payment.

​

On May 2, 2024, the Xcel Parties made a written demand for arbitration and commenced an arbitration proceeding against the LG Parties for, among other things, alleged breaches of the Asset Purchase Agreement and alleged breaches of Ms. Goldstein’s employment agreement with the Company. The Company is seeking compensatory damages and consequential damages. Additionally, on May 2, 2024, the Company terminated the employment agreement and the consulting agreement between the Company and LG Ltd. The parties are negotiating to resolve all outstanding disputes and, if an agreement is reached, it may include, among other things, a disposition of the Lori Goldstein brands and related assets to LG Ltd. By agreement between the Company and Ms. Goldstein, while negotiations continue, Ms. Goldstein is continuing to comply with her material obligations to QVC. There can be no assurance that these disputes will be resolved in a manner favorable to the Company or at all.

​

As of the filing date of this Quarterly Report on Form 10-Q, there have been no definitive agreements or terms agreed to by the parties, and it is not certain when or if an agreement will be executed.

​

12.    Subsequent Events

IM Topco

On April 12, 2024, the Company, WHP, and IM Topco entered into amendments of the May 27, 2022 (and as subsequently amended) membership purchase agreement and the related business venture agreement. Under these amendments, the parties agreed to the following:

●

The purchase price adjustment provision within the membership purchase agreement was waived until the measurement period ending September 30, 2025.

●

If IM Topco royalties are less than $13.5 million for the twelve-month period ending March 31, 2025 or less than $18.0 million for the year ending December 31, 2025, Xcel shall transfer equity interests in IM Topco to WHP equal to 12.5% of the total outstanding equity interests of IM Topco, such that Xcel’s ownership interest in IM Topco would decrease from 30% to 17.5%, and WHP’s ownership interest in IM Topco would increase from 70% to 82.5%. In addition, Xcel shall be obligated to make such transfer to WHP if Xcel fails to make certain payments owed to IM Topco by October 10, 2024 under the second amendment (which totaled $375,000 as of December 31, 2023 and March 31, 2024). In April 2024, Xcel paid $100,000 of this amount to WHP.

●

On and after January 1, 2026, WHP shall receive 50% of the Net Cash Flow which would otherwise be payable to Xcel, until WHP has received an aggregate amount of additional Net Cash Flow equal to $1.0 million.

​

21

Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995. The statements that are not historical facts contained in this report are forward-looking statements that involve a number of known and unknown risks, uncertainties and other factors, all of which are difficult or impossible to predict and many of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks are detailed in the Risk Factors section of our Form 10-K for the fiscal year ended December 31, 2023, as filed with the SEC on April 19, 2024. The words “believe,” “anticipate,” “expect,” “continue,” “estimate,” “appear,” “suggest,” “goal,” “potential,” “predicts,” “seek,” “will,” “confident,” “project,” “provide,” “plan,” “likely,” “future,” “ongoing,” “intend,” “may,” “should,” “would,” “could,” “guidance,” and similar expressions identify forward-looking statements.

Overview

Xcel Brands, Inc. (“Xcel,” the “Company,” “we,” “us,” or “our”) is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Xcel was founded in 2011 with a vision to reimagine shopping, entertainment, and social media as one thing. Currently, the Company’s brand portfolio consists of the following:

●

the Halston Brand, Ripka Brand, C Wonder Brand, and Lori Goldstein Brand, which are wholly owned by the Company.

●

the Longaberger Brand, which we manage through our 50% ownership interest in Longaberger Licensing, LLC, and the CB Brand, which is a co-owned brand between Xcel and Christie Brinkley; and

●

the Isaac Mizrahi Brand, in which we hold a 30% noncontrolling interest and continue to contribute to the operations of the brand through a service agreement.

We also own a 30% interest in ORME Live Inc., a short-form video and social commerce marketplace that launched in the first quarter of 2024.

Xcel continues to pioneer a true omni-channel and social commerce sales strategy which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop. Our brands have generated over $5 billion in retail sales via live streaming in interactive television and digital channels alone, and our brands collectively reach over 5 million social media followers through Facebook, Instagram, and TikTok. All of the followers may not be unique followers, as many followers may follow multiple brands and follow our brands on multiple platforms.

Our objective is to build a diversified portfolio of lifestyle consumer products brands through organic growth and the strategic acquisition of new brands. To grow our brands, we are focused on the following primary strategies:

●

distribution and/or licensing of our brands for sale through interactive television (e.g., QVC, HSN, The Shopping Channel, JTV, etc.);

●

licensing of our brands to retailers that sell to the end consumer;

●

direct-to-consumer distribution of our brands through e-commerce and live streaming;

●

licensing our brands to manufacturers and retailers for promotion and distribution through e-commerce, social commerce, and traditional brick-and-mortar retail channels; and

22

Table of Contents

●

acquiring additional consumer brands and integrating them into our operating platform, and leveraging our operating infrastructure and distribution relationships.

We believe that Xcel offers a unique value proposition to our retail and direct-to-consumer customers and our licensees for the following reasons:

●

our management team, including our officers’ and directors’ experience in, and relationships within the industry;

●

our deep knowledge, expertise, and proprietary technology in live streaming and social commerce;

●

our design, sales, marketing, and technology platform that enables us to design trend-right product; and

●

our significant media and internet presence.

Summary of Operating Results

Three months ended March 31, 2024 (the “current quarter”) compared with the three months ended March 31, 2023 (the “prior year quarter”)

Revenues

Current quarter net revenue decreased approximately $3.9 million to $2.2 million from $6.1 million for the prior year quarter. This decline was almost entirely attributable to the decrease in net product sales to zero, due to the exit from our wholesale apparel and fine jewelry sales operations and outsourcing of our Longaberger business as part of the restructuring and transformation of our business operating model in 2023. Net licensing revenue was approximately $2.2 million in both the current quarter and prior year quarter, and with a decrease of less than 2% was essentially flat year-over-year.

Cost of Goods Sold

Current quarter cost of goods sold was zero, compared with $2.7 million for the prior year quarter. This was driven by the aforementioned exit from our wholesale and direct-to-consumer operations as part of the 2023 business model restructuring.

Direct Operating Costs and Expenses

Direct operating costs and expenses decreased approximately $3.0 million from $7.0 million in the prior year quarter to $4.0 million in the current quarter. This decrease was primarily attributable to the 2023 restructuring and transformation of our business operating model, which included reductions in staffing levels as well as related reductions in other overhead costs.

Other Operating Costs and Expenses (Income)

Depreciation and amortization expense was approximately $1.6 million and $1.8 million in the current quarter and prior year quarter, respectively.

We recognized equity method losses related to our equity investments in unconsolidated affiliates (IM Topco, LLC and Orme Live Inc.) of $0.53 million and $0.52 million for the current quarter and prior year quarter, respectively, due to the operations of those businesses and the distribution provisions applicable to each.

23

Table of Contents

During the current quarter, we recognized asset impairment charges of $2.3 million related to our exit from and sublease of our offices at 1333 Broadway, of which $1.9 million related to the operating lease right-of-use asset and $0.4 million related to leasehold improvements at that location.

Income Taxes

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% for both periods, resulting in an income tax benefit of $0 for both periods.

For both the current quarter and the prior year quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

Net Loss Attributable to Xcel Brands, Inc. Stockholders

We had a net loss of $6.3 million for the current quarter, compared with a net loss of $5.6 million for the prior year quarter, due to the combination of the factors outlined above.

Non-GAAP Net (Loss) Income, Non-GAAP Diluted EPS, and Adjusted EBITDA

We had a non-GAAP net loss of approximately $1.8 million, or $0.09 per diluted share (“non-GAAP diluted EPS”), for the current quarter and a non-GAAP net loss of $3.6 million, or $0.18 per diluted share, for the prior year quarter. Non-GAAP net (loss) income is a non-GAAP unaudited term, which we define as net (loss) income attributable to Xcel Brands, Inc. stockholders, exclusive of amortization of trademarks, our proportional share of trademark amortization of equity method investees, stock-based compensation and cost of licensee warrants, asset impairment charges, and income taxes. Non-GAAP net income and non-GAAP diluted EPS measures do not include the tax effect of the aforementioned adjusting items, due to the nature of these items and the Company’s tax strategy.

We had Adjusted EBITDA of approximately $(1.6) million for the current quarter, compared with approximately $(3.2) million for the prior year quarter. Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net (loss) income attributable to Xcel Brands, Inc. stockholders before depreciation and amortization, our proportional share of trademark amortization of equity method investees, interest and finance expenses (including loss on extinguishment of debt, if any), income taxes, other state and local franchise taxes, stock-based compensation and cost of licensee warrants, gains on sales of assets and investments, gain on lease termination, asset impairment charges, and costs associated with restructuring of operations.

Management uses non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to the Company’s results of operations. Management believes non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus, these non-GAAP measures provide supplemental information to assist investors in evaluating the Company’s financial results.

Non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA in a different manner than we calculate these measures.

In evaluating non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this report. Our presentation of non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by

24

Table of Contents

these expenses or any other unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP net loss:

​

​	​	​	​	​	​	​
​		Three Months Ended
​	​	March 31,
($ in thousands)		2024			2023
Net loss attributable to Xcel Brands, Inc. stockholders	​	$	(6,294)	​	$	(5,643)
Amortization of trademarks	​		1,519	​		1,520
Proportional share of trademark amortization of equity method investee	​	​	515	​	​	515
Stock-based compensation and cost of licensee warrants	​		144	​		57
Asset impairment charges	​	​	2,295	​	​	—
Non-GAAP net loss	​	$	(1,821)	​	$	(3,551)

​

The following table is a reconciliation of diluted net loss per share (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP diluted EPS:

​

​	​	​	​	​	​	​
​	​	Three Months Ended
​	​	March 31,
​		2024			2023
Diluted net loss per share	​	$	(0.31)	​	$	(0.29)
Amortization of trademarks	​		0.07	​		0.08
Proportional share of trademark amortization of equity method investee	​	​	0.03	​	​	0.03
Stock-based compensation and cost of licensee warrants	​		0.01	​		0.00
Asset impairment charges	​	​	0.11	​	​	—
Non-GAAP diluted EPS	​	$	(0.09)	​	$	(0.18)
Non-GAAP weighted average diluted shares	​		20,374,920	​		19,633,194

​

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to Adjusted EBITDA:

​

​	​	​	​	​	​	​
​	​	Three Months Ended
​	​	March 31,
($ in thousands)		2024			2023
Net loss attributable to Xcel Brands, Inc. stockholders	​	$	(6,294)	​	$	(5,643)
Asset impairment charges	​		2,295	​		—
Depreciation and amortization	​		1,589	​		1,797
Proportional share of trademark amortization of equity method investee	​	​	515	​	​	515
Interest and finance expense	​		150	​		25
State and local franchise taxes	​		12	​		21
Stock-based compensation and cost of licensee warrants	​		144	​		57
Adjusted EBITDA	​	$	(1,589)	​	$	(3,228)

​

Liquidity and Capital Resources

General

As of March 31, 2024 and December 31, 2023, our unrestricted cash and cash equivalents were $1.6 million and $3.0 million, respectively. Restricted cash at March 31, 2024 (included within other assets in the condensed consolidated balance sheet) consisted of $0.7 million of cash deposited with Israel Discount Bank of New York as collateral for a standby letter of credit associated with a real estate lease; there was no restricted cash as of December 31, 2023.

25

Table of Contents

Our principal capital requirements have been to fund working capital needs, acquire new brands, and to a lesser extent, capital expenditures. Our current “licensing plus” operating model is a working capital light business model, and generally does not require material capital expenditures. As of March 31, 2024, we have no significant commitments for future capital expenditures.

Working Capital

Our working capital (current assets less current liabilities, excluding the current portion of operating lease obligations, deferred revenue, and any contingent obligations payable in common stock) was $2.1 million and $2.9 million as of March 31, 2024 and December 31, 2023, respectively.

Liquidity and Management’s Plans  

We incurred a net loss attributable to Company stockholders of approximately $6.3 million during the three months ended March 31, 2024 (which included non-cash expenses of approximately $4.6 million), and had an accumulated deficit of approximately $60.1 million as of March 31, 2024. Net cash used in operating activities was approximately $2.6 million for the three months ended March 31, 2024. These factors, along with our current levels of cash and working capital, raise uncertainties about the Company’s ability to continue as a going concern.

​

During the year ended December 31, 2023, management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting its business from a wholesale/licensing hybrid model into a “licensing plus” model. To affect this transition, the Company entered into various new licensing agreements and joint venture arrangements with best-in-class business partners. These restructuring initiatives were substantially completed as of June 30, 2023. Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of December 31, 2023, the Company had reduced payroll costs by approximately $6 million and operating expenses (excluding non-recurring charges related to the restructuring) by approximately $9 million, on an annualized basis when compared to the corresponding periods in the prior year.

Also during the year ended December 31, 2023, the Company entered into a new term loan agreement in the amount of $5 million, which provided the Company with additional liquidity.

Further, in March 2024, the Company issued new shares of common stock for net proceeds of approximately $1.9 million, which provided the Company with additional liquidity.

Based on the aforementioned events and changes, management expects that existing cash and future operating cash flows will be adequate to meet the Company’s operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q; therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of March 31, 2024, have been alleviated.

​

Commentary on the components of our cash flows for the current quarter as compared with the prior year quarter is set forth below.

Operating Activities

Net cash used in operating activities was approximately $2.61 million in the current quarter, compared with approximately $2.92 million in the prior year quarter.

The current quarter net cash used in operating activities was primarily attributable to the combination of the net loss of $(6.35) million plus non-cash items of approximately $4.59 million and the net change in operating assets and liabilities of approximately $(0.85) million. Non-cash items were primarily comprised of asset impairment charges of approximately $2.30 million, $1.59 million of depreciation and amortization, and the $0.53 million undistributed proportional share of net loss of equity method investees. The net change in operating assets and liabilities was primarily comprised of (i) a

26

Table of Contents

decrease in deferred revenue of approximately $(0.22) million, mainly related to the Halston Master License agreement, (ii) a decrease in various operating liabilities of $(0.56) million, and (iii) a decrease in lease-related assets and liabilities of $(0.24) million.

The prior year quarter net cash used in operating activities was primarily attributable to the combination of the net loss of $(5.94) million plus non-cash items of approximately $2.37 million and the net change in operating assets and liabilities of approximately $0.65 million. Non-cash items were primarily comprised of $1.80 million of depreciation and amortization and the $0.52 million undistributed proportional share of net loss of an equity method investee. The net change in operating assets and liabilities was primarily comprised of increases in various operating liabilities (including deferred revenue) of approximately $1.40 million, partially offset by an increase in accounts receivable of $(0.86) million.

Investing Activities

There was no net cash used in or provided by investing activities for the current quarter.

Net cash used in investing activities for the prior year quarter consisted of approximately $0.08 million of capital expenditures, primarily related to software.

Financing Activities

Net cash provided by financing activities was $1.90 million, due to the financing transactions described below.

There was no net cash used in or provided by financing activities in the prior year quarter.

Public Offering and Private Placement Transactions

On March 15, 2024, the Company entered into an underwriting agreement with Craig-Hallum Capital Group LLC (the “Representative”), as the representative of the underwriters, relating to a firm commitment underwritten public offering (the “Offering”) of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share.

The closing of the Offering occurred on March 19, 2024. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company, were approximately $1.7 million.

Upon closing of the Offering, the Company issued the Representative certain warrants to purchase up to 182,952 shares of common stock (the “Representative’s Warrants”) as compensation. The Representative’s Warrants will be exercisable at a per share exercise price of $0.8125. The Representative’s Warrants are exercisable, in whole or in part, during the four and one-half-year period commencing 180 days from the commencement of sales of the shares of common stock in the Offering.

In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering.

The aggregate number of shares of common stock issued from the Offering and the Private Placement was 3,579,064 shares and the total net proceeds received was approximately $1.9 million.

27

Table of Contents

Contingent Obligation – Isaac Mizrahi Transaction

In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi brand, we agreed with WHP (the buyer) that, in the event that IM Topco, LLC receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP would be entitled to receive from us up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by us in either cash or equity interests in IM Topco, LLC held by us.

In November 2023, this agreement was amended such that the purchase price adjustment provision was waived until the measurement period ending March 31, 2024. No amount has been recorded in the Company’s condensed consolidated balance sheets related to this contingent obligation.

In April 2024, the Company, WHP, and IM Topco, LLC entered into an amendment to this agreement, such that the purchase price adjustment provision within the membership purchase agreement was waived until the measurement period ending September 30, 2025. Additionally, the parties agreed that if IM Topco, LLC royalties are less than $13.5 million for the twelve-month period ending March 31, 2025 or less than $18.0 million for the year ending December 31, 2025, Xcel shall transfer equity interests in IM Topco, LLC to WHP, such that Xcel’s ownership interest in IM Topco, LLC would decrease from 30% to 17.5%, and WHP’s ownership interest in IM Topco, LLC would increase from 70% to 82.5%.

Contingent Obligation – Lori Goldstein Earn-Out

In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, we agreed to pay the seller additional cash consideration of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid.

As of December 31, 2022, based on the performance of the Lori Goldstein brand to date, approximately $0.2 million of additional consideration was earned by the seller, and thus $0.2 million of the balance was recorded as a current liability and $6.4 million was recorded as a long-term liability. The $0.2 million of additional consideration was paid to the seller during 2023.

Based on the performance of the Lori Goldstein through December 31, 2023, approximately $1.0 million of incremental additional consideration was earned by the seller, which will be paid out in 2024. During the current quarter, the Company paid approximately $0.3 million of the $1.0 million earned, and as of March 31, 2024, $0.7 million of the remaining balance was recorded as a current liability and $5.4 million was recorded as a long-term liability.

Other Factors

We continue to seek to expand and diversify the types of licensed products being produced under our brands. We plan to continue to diversify the distribution channels within which licensed products are sold, in an effort to reduce dependence on any particular retailer, consumer, or market sector within each of our brands. The Halston brand, C Wonder brand, Lori Goldstein brand, and TowerHill by Christie Brinkley brand have a core business in fashion apparel and accessories. The Ripka brand is a fine jewelry business, and the Longaberger brand focuses on home good products, which we believe helps diversify our industry focus while at the same time complements our business operations and relationships.

While the 2022 sale of a majority interest in the Isaac Mizrahi brand resulted in a decrease in our revenues, as that brand represented a significant portion of our historical revenues, we are taking actions to replace those revenues in the long-term with new strategic business initiatives, as we concentrate our resources on growing our brands, launching new brands, and entering into new business partnerships. We continue to seek new opportunities, including expansion through interactive television, live streaming, and additional domestic and international licensing arrangements, and acquiring and collaborating with additional brands, launching the C Wonder by Christian Siriano business on HSN, and the planned May 2024 launch of the TowerHill by Christie Brinkley brand.

28

Table of Contents

During 2023, we restructured our business operations by shifting our business from a wholesale/licensing hybrid model into a “licensing plus” business model. These efforts included entering into new structured contractual arrangements with best-in-class business partners in order to more efficiently operate our wholesale and e-commerce businesses and reduce and better manage our exposure to operating risks. These restructuring initiatives, on a go-forward basis, are expected to provide us with approximately $15 million of cost savings on an annualized basis compared to our previous operating model.

Nonetheless, we continue to face a number of headwinds in the current macroeconomic environment. Poor economic and market conditions, including inflation and rising consumer debt levels, may negatively impact market sentiment, decreasing the demand for apparel, footwear, accessories, fine jewelry, home goods, and other consumer products, which would adversely affect our operating income and results of operations. If we are unable to take effective measures in a timely manner to mitigate the impact of inflation and/or a potential recession, our business, financial condition, and results of operations could be adversely affected.

Our long-term success, however, will still remain largely dependent on our ability to build and maintain our brands’ awareness and continue to attract wholesale and direct-to-consumer customers, and contract with and retain key licensees and business partners, as well as our and our licensees’ ability to accurately predict upcoming fashion and design trends within their respective customer bases and fulfill the product requirements of the particular retail channels within the global marketplace. Unanticipated changes in consumer fashion preferences and purchasing patterns, slowdowns in the U.S. economy, changes in the prices of supplies, consolidation of retail establishments, and other factors noted in Item 1A of our most recent Annual Report on Form 10-K could adversely affect our licensees’ ability to meet and/or exceed their contractual commitments to us and thereby adversely affect our future operating results.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, results of operations, or liquidity.

Critical Accounting Policies and Estimates

The preparation of our unaudited condensed consolidated financial statements in conformity with GAAP requires management to exercise judgment. We exercise considerable judgment with respect to establishing sound accounting policies and in making estimates and assumptions that affect the reported amounts of our assets and liabilities, our recognition of revenues and expenses, and disclosure of commitments and contingencies at the date of the financial statements. We evaluate our estimates and judgments on an on-going basis. We base our estimates and judgments on a variety of factors, including our historical experience, knowledge of our business and industry, and current and expected economic conditions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We periodically re-evaluate our estimates and assumptions with respect to these judgments and modify our approach when circumstances indicate that modifications are necessary. While we believe that the factors we evaluate provide us with a meaningful basis for establishing and applying sound accounting policies, we cannot guarantee that the results will always be accurate. Because the determination of these estimates requires the exercise of judgment, actual results could differ from such estimates.

Please refer to our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 19, 2024, for a discussion of our critical accounting policies and estimates. During the three months ended March 31, 2024, there were no material changes to our accounting policies.

​

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.

​

29

Table of Contents

ITEM 4.    CONTROLS AND PROCEDURES

A. EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES:

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of March 31, 2024, the end of the period covered by this report. Based on, and as of the date of such evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of March 31, 2024, due to the material weakness described below.

The basis for the conclusion that such internal control was ineffective included the following considerations:

●

The Company was unable to file its Annual Report on Form 10-K within the time specified in SEC rules and forms, due to a failure to obtain audited financial statements of the Company’s investment in an equity method investee. Additional procedures were required for the Company’s audit, which impacted on the resources required to timely file the Company’s Form 10-K.

●

During the middle of February 2024, our equity method investee engaged an independent audit accounting firm (separate from Marcum, LLP) to conduct its audit. We agreed to pay for all fees of the audit, and on February 23, 2024, paid a retainer to the audit firm, in accordance with the engagement. The audit firm was the same firm which conducted the audit for the year ended December 31, 2022 for the same equity method investee and delivered timely such audited financial statements for such prior audit. However, the audit firm for the equity method investee has not completed the 2023 audit on a timely basis. It was determined their progress was significantly deficient, and there would not be sufficient time to engage a new audit firm to receive timely, audited financial statements of the equity method investee. The determination was made to terminate this firm’s 2023 engagement and have a new firm engaged to provide the 2023 audited financial statements.

Going forward, the Company will arrange for the appointment of a different auditor by the equity method investee and take a more active role in communicating with the auditor of the equity method investee, including assessing progress and timing.

B. CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING:

There have not been any changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

​

30

Table of Contents

PART II. OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable.

​

With the exception of the matter described in detail below, in the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows.

​

On February 16, 2024, counsel to Lori Goldstein, a brand spokesperson for the Company, advised the Company that the Company was in material breach of the Asset Purchase Agreement dated March 31, 2021 (the “Asset Purchase Agreement”) by and among Gold Licensing LLC (“Gold” and, together with Xcel, the ”Xcel Parties”), a subsidiary of the Company, and Lori Goldstein and Lori Goldstein, Ltd. (“LG Ltd” and, together with Lori Goldstein, the “LG Parties”) for failure to pay $963,642 earned in 2023 in accordance with the earn-out provisions of the agreement. The Company does not dispute the amount of the Lori Goldstein earn-out that was achieved in 2023, and advised Ms. Goldstein that due to the alleged breaches described below, the Company was not willing to pay this amount at such time. The Company subsequently paid approximately $241,000 of the earn-out payment.

​

On May 2, 2024, the Xcel Parties made a written demand for arbitration and commenced an arbitration proceeding against the LG Parties for, among other things, alleged breaches of the Asset Purchase Agreement and alleged breaches of Ms. Goldstein’s employment agreement with the Company. The Company is seeking compensatory damages and consequential damages. Additionally, on May 2, 2024, the Company terminated the employment agreement and the consulting agreement between the Company and LG Ltd. The parties are negotiating to resolve all outstanding disputes and, if an agreement is reached, it may include, among other things, a disposition of the Lori Goldstein brands and related assets to LG Ltd. By agreement between the Company and Ms. Goldstein, while negotiations continue, Ms. Goldstein is continuing to comply with her material obligations to QVC. There can be no assurance that these disputes will be resolved in a manner favorable to the Company or at all.

​

ITEM 1A.    RISK FACTORS

​

We operate in a highly competitive industry that involves numerous known and unknown risks and uncertainties that could impact our operations. The risks described in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2023 are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our financial condition and/or operating results.

​

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the representative were approximately $0.3 million. The purchase of the Private Placement Shares closed on March 19, 2024.

​

ITEM 3.    DEFAULTS UPON SENIOR SECURITIES

None.

​

31

Table of Contents

ITEM 4.    MINE SAFETY DISCLOSURES

Not applicable.

​

ITEM 5.    OTHER INFORMATION

None.

​

ITEM 6.    EXHIBITS

The following exhibits are filed herewith:

​

31.1 Rule 13a-14(a)/15d-14(a) Certification (CEO)

31.2 Rule 13a-14(a)/15d-14(a) Certification (CFO)

32.1 Section 1350 Certification (CEO) *

32.2 Section 1350 Certification (CFO) *

101.INS Inline XBRL Instance Document

101.SCH Inline XBRL Taxonomy Extension Schema Document

101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF Inline XBRL Taxonomy Extension Definitions Linkbase Document

101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document

104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

​

* Furnished herewith.

​

​

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: May 20, 2024	By:	/s/ Robert W. D’Loren
		Name: Robert W. D’Loren
		Title: Chairman and Chief Executive Officer
	By:	/s/ James Haran
		Name: James Haran
		Title: Chief Financial Officer and Vice President

​

​

​

32

EXHIBIT 31.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert W. D’Loren, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 of Xcel Brands, Inc. (the “Company”).

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

​

​

​	​	​
May 20, 2024	By:	/s/ Robert W. D’Loren
		Name: Robert W. D’Loren
		Title: Chairman and Chief Executive Officer

​

---

EXHIBIT 31.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, James Haran, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 of Xcel Brands, Inc. (the “Company”).

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

​

​

May 20, 2024	By:	/s/ James Haran
		Name: James Haran
​	​	Title: Chief Financial Officer and Vice President
		​

​

---

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Xcel Brands, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert W. D’Loren, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

​

​

​	​	​
May 20, 2024	By:	/s/ Robert W. D’Loren
		Name: Robert W. D’Loren
		Title: Chairman and Chief Executive Officer

​

---

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Xcel Brands, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James Haran, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

​

May 20, 2024	By:	/s/ James Haran
		Name: James Haran
		Title: Chief Financial Officer and Vice President

​

---

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2024	May 01, 2024
Document And Entity Information [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-37527
Entity Registrant Name	XCEL BRANDS, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	76-0307819
Entity Address, Address Line One	550 Seventh Avenue, 11th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10018
City Area Code	347
Local Phone Number	727-2474
Title of 12(b) Security	Common Stock, $0.001 par value per share
Trading Symbol	XELB
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		23,492,117
Entity Central Index Key	0001083220
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 1,552	$ 2,998
Accounts receivable, net of allowances for credit losses of $75 at March 31, 2024 and December 31, 2023	3,603	3,454
Inventory	445	453
Prepaid expenses and other current assets	471	398
Total current assets	6,071	7,303
Non-current Assets:
Property and equipment, net	133	634
Operating lease right-of-use assets	2,535	4,453
Trademarks and other intangibles, net	39,986	41,520
Equity method investment in IM Topco, LLC	17,070	17,585
Other assets	969	165
Total non-current assets	60,693	64,357
Total Assets	66,764	71,660
Current Liabilities:
Accounts payable, accrued expenses and other current liabilities	1,918	2,236
Deferred revenue	889	889
Accrued income taxes payable	372	372
Current portion of operating lease obligations	1,278	1,258
Current portion of long-term debt	1,000	750
Current portion of contingent obligation	723	964
Total current liabilities	6,180	6,469
Long-Term Liabilities:
Long-term portion of operating lease obligations	3,694	4,021
Deferred revenue	3,333	3,556
Long-term debt, net, less current portion	3,747	3,971
Long-term portion of contingent obligations	5,432	5,432
Other long-term liabilities	506	40
Total long-term liabilities	16,712	17,020
Total Liabilities	22,892	23,489
Commitments and Contingencies
Stockholders' Equity:
Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding
Common stock, $.001 par value, 50,000,000 shares authorized, and 23,452,117 and 19,795,053 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	23	20
Paid-in capital	105,904	103,861
Accumulated deficit	(60,143)	(53,849)
Total Xcel Brands, Inc. stockholders' equity	45,784	50,032
Noncontrolling interest	(1,912)	(1,861)
Total Stockholders' Equity	43,872	48,171
Total Liabilities and Stockholders' Equity	$ 66,764	$ 71,660

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Accounts receivable, net of allowances	$ 75
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	23,452,117	19,795,053
Common stock, shares outstanding (in shares)	23,452,117	19,795,053

Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues
Net revenue	$ 2,184,000	$ 6,050,000
Cost of goods sold		2,693,000
Gross profit	2,184,000	3,357,000
Direct operating costs and expenses
Salaries, benefits and employment taxes	1,933,000	3,465,000
Other selling, general and administrative expenses	2,029,000	3,493,000
Total direct operating costs and expenses	3,962,000	6,958,000
Operating loss before other operating costs and expenses	(1,778,000)	(3,601,000)
Other operating costs and expenses (income)
Depreciation and amortization	1,589,000	1,797,000
Asset impairment charges	2,295,000
Loss from equity method investment	533,000	515,000
Operating loss	(6,195,000)	(5,913,000)
Interest and finance expense
Interest expense	146,000
Other interest and finance charges, net	4,000	25,000
Total interest and finance expense	150,000	25,000
Loss before income taxes	(6,345,000)	(5,938,000)
Income tax provision (benefit)	0	0
Net loss	(6,345,000)	(5,938,000)
Net loss attributable to noncontrolling interest	(51,000)	(295,000)
Net loss attributable to Xcel Brands, Inc. stockholders	$ (6,294,000)	$ (5,643,000)
Loss per common share attributable to Xcel Brands, Inc. stockholders:
Basic net loss income per share	$ (0.31)	$ (0.29)
Diluted net loss income per share	$ (0.31)	$ (0.29)
Weighted average number of common shares outstanding:
Basic weighted average number of shares outstanding	20,374,920	19,633,194
Diluted weighted average common shares outstanding	20,374,920	19,633,194
Net licensing revenue
Revenues
Net revenue	$ 2,184,000	$ 2,222,000
Net sales
Revenues
Net revenue		$ 3,828,000

Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Public Offering and Private Placement Common Stock	Public Offering and Private Placement Paid-in Capital	Public Offering and Private Placement	Common Stock Consultants	Common Stock	Paid-in Capital Consultants	Paid-in Capital	Accumulated Deficit	Noncontrolling Interest	Consultants	Total
Balances at Dec. 31, 2022					$ 20		$ 103,592	$ (32,797)	$ (676)		$ 70,139
Balances (in shares) at Dec. 31, 2022					19,624,860
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense related to stock options and restricted stock							51				51
Shares issued to consultant in connection with stock grant						$ 6				$ 6
Shares issued to consultant in connection with stock grant (in shares)				8,334
Net loss								(5,643)	(295)		(5,938)
Balances at Mar. 31, 2023					$ 20		103,649	(38,440)	(971)		$ 64,258
Balances (in shares) at Mar. 31, 2023					19,633,194
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock, shares issued (in shares)											19,795,053
Balances at Dec. 31, 2023					$ 20		103,861	(53,849)	(1,861)		$ 48,171
Balances (in shares) at Dec. 31, 2023					19,795,053
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense related to stock options and restricted stock							36				36
Shares issued in connection with stock grant						$ 98				$ 98
Shares issued in connection with stock grant (in shares)				78,000
Shares issued in connection with public offering and private placement transactions, net of transaction costs	$ 3	$ 1,899	$ 1,902								1,902
Contra-revenue related to warrants granted to licensee							10				10
Net loss								(6,294)	(51)		(6,345)
Balances at Mar. 31, 2024					$ 23		$ 105,904	$ (60,143)	$ (1,912)		$ 43,872
Balances (in shares) at Mar. 31, 2024					23,452,117
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued in connection with public offering and private placement transactions, net of transaction costs			$ 1,900
Common stock, shares issued (in shares)			3,579,064
Common stock, shares issued (in shares)	3,579,064										23,452,117

Consolidated Statements of Cash Flows $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)
Cash flows from operating activities
Net loss	$ (6,345)	$ (5,938)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	1,589	1,797
Asset impairment charges	2,295
Amortization of deferred finance costs included in interest expense	26
Stock-based compensation and cost of licensee warrants	144	57
Undistributed proportional share of net loss of equity method investee	533	515
Changes in operating assets and liabilities:
Accounts receivable	(149)	(859)
Inventory	8	(254)
Prepaid expenses and other current and non-current assets	(156)	425
Deferred revenue	(223)	240
Accounts payable, accrued expenses, accrued income taxes payable, and other current liabilities	(560)	1,156
Lease-related assets and liabilities	(237)	(54)
Other long-term liabilities	466
Net cash used in operating activities	(2,609)	(2,915)
Cash flows from investing activities
Purchase of property and equipment		(81)
Net cash provided by investing activities		(81)
Cash flows from financing activities
Proceeds from public offering and private placement transactions, net of transaction costs	1,902
Net cash provided by (used in) financing activities	1,902
Net decrease in cash and cash equivalents	(707)	(2,996)
Cash and cash equivalents at beginning of year	2,998	4,608
Cash and cash equivalents at end of year	2,291	1,612
Reconciliation to amounts on consolidated balance sheets:
Cash and cash equivalents	1,552	1,612
Restricted cash	739
Total cash, cash equivalents, and restricted cash	2,291	1,612
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	$ 119
Cash paid during the period for income taxes		$ 16

Nature of Operations, Background, and Basis of Presentation	3 Months Ended
	Mar. 31, 2024
Nature of Operations, Background, and Basis of Presentation [Abstract]
Nature of Operations, Background, and Basis of Presentation	1. Nature of Operations, Background, and Basis of Presentation The accompanying condensed consolidated balance sheet as of December 31, 2023 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of Xcel Brands, Inc. and its subsidiaries (the “Company” or "Xcel"). The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on April 19, 2024. The Company is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, fine jewelry, home goods and other consumer products, and the acquisition of dynamic consumer lifestyle brands. Currently, the Company’s brand portfolio consists of the Halston brands (the "Halston Brand"), the Judith Ripka brands (the "Ripka Brand"), the C Wonder brands (the "C Wonder Brand"), the LOGO by Lori Goldstein brand (the “Lori Goldstein Brand”), the Longaberger brand (the “Longaberger Brand”), the Isaac Mizrahi brands (the "Isaac Mizrahi Brand"), the TowerHill by Christie Brinkley brand (the “CB Brand”), and other proprietary brands. ● The Halston Brand, Ripka Brand, C Wonder Brand, and Lori Goldstein Brand are wholly owned by the Company. ● The Company manages the Longaberger Brand through its 50% ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party. ● The Company holds a noncontrolling interest in the Isaac Mizrahi Brand through its 30% ownership interest in IM Topco, LLC; the Company accounts for its interest in IM Topco, LLC using the equity method of accounting. ● The CB Brand is a new co-branded collaboration between Xcel and Christie Brinkley, announced in 2023 and planned to launch by the end of May 2024. The Company also owns a 30% interest in ORME Live, Inc. (“ORME”), a short-form video and social commerce marketplace that is planned to launch in 2024. The Company primarily generates revenue through the licensing of its brands through contractual arrangements with manufacturers and retailers. The Company, through its licensees, distributes through an omni-channel and social commerce sales strategy, which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, traditional brick-and-mortar retailers, and e-commerce channels, to be everywhere its customers shop. Prior to and for a portion of 2023, the Company also engaged in wholesale and direct-to-consumer sales of products under its brands. The Company’s former wholesale and direct-to-consumer operations were presented as "Net sales" and "Cost of goods sold" in the condensed consolidated statements of operations, separately from the Company’s licensing revenues. Liquidity and Management’s Plans   The Company incurred a net loss attributable to Company stockholders of approximately $6.3 million during the three months ended March 31, 2024 (which included non-cash expenses of approximately $4.6 million), and had an accumulated deficit of approximately $60.1 million as of March 31, 2024. Net cash used in operating activities was approximately $2.6 million for the three months ended March 31, 2024. The Company had working capital (current assets less current liabilities, excluding the current portions of lease obligations, deferred revenue, and any contingent obligations payable in common stock) of approximately $2.1 million as of March 31, 2024. The Company’s unrestricted cash and cash equivalents were approximately $1.6 million as of March 31, 2024. The aforementioned factors raise uncertainties about the Company’s ability to continue as a going concern. ​ During the year ended December 31, 2023, management implemented a plan to mitigate an expected shortfall of capital and to support future operations by shifting its business from a wholesale/licensing hybrid model into a “licensing plus” model. To affect this transition, the Company entered into various new licensing agreements and joint venture arrangements with best-in-class business partners. These restructuring initiatives were substantially completed as of June 30, 2023. Management believes that this evolution of the Company’s operating model will provide the Company with significant cost savings and allow the Company to reduce and better manage its exposure to operating risks. As of December 31, 2023, the Company had reduced payroll costs by approximately $6 million and operating expenses (excluding non-recurring charges related to the restructuring) by approximately $9 million, on an annualized basis when compared to the corresponding periods in the prior year. Also during the year ended December 31, 2023, the Company entered into a new term loan agreement in the amount of $5 million, which provided the Company with additional liquidity. Further, in March 2024, the Company issued new shares of common stock for net proceeds of approximately $1.9 million, which provided the Company with additional liquidity. Based on the aforementioned events and changes, management expects that existing cash and future operating cash flows will be adequate to meet the Company’s operating needs, term debt service obligations, and capital expenditure needs, for at least the twelve months subsequent to the filing date of this Quarterly Report on Form 10-Q; therefore, such conditions and uncertainties with respect to the Company’s ability to continue as a going concern as of March 31, 2024, have been alleviated. ​

Investments in Unconsolidated Affiliates and Variable Interest Entities	3 Months Ended
	Mar. 31, 2024
Equity Method Investment, Summarized Financial Information [Abstract]
Investments in Unconsolidated Affiliates and Variable Interest Entities	2.      Investments in Unconsolidated Affiliates and Variable Interest Entities   Investment in IM Topco, LLC On May 27, 2022, Xcel (along with IM Topco, LLC (“IM Topco”) and IM Brands, LLC (“IMB”), both wholly owned subsidiaries of the Company) and IM WHP, LLC (“WHP”), a subsidiary of WHP Global, a private equity-backed brand management and licensing company, entered into a membership purchase agreement. Pursuant to this agreement, on May 31, 2022, (i) the Company contributed assets owned by IMB, including the Isaac Mizrahi Brand trademarks and other intellectual property rights relating thereto into IM Topco, and (ii) the Company sold 70% of the membership interests of IM Topco to WHP. The Company accounts for its 30% interest in the ongoing operations of IM Topco as other operating costs and expenses under the equity method of accounting. Pursuant to the business venture agreement between the Company and WHP governing the operation of IM Topco, IM Topco’s net cash flow (as defined in the agreement) shall be distributed to the members during each fiscal year no less than once per fiscal quarter, as follows: (i) first, 100% to WHP, until WHP has received an aggregate amount during such fiscal year equal to $8,852,000 (subject to adjustment in certain circumstances as set forth in the agreement); (ii) second, 100% to Xcel, until Xcel has received an aggregate amount during such fiscal year equal to $1,316,200 (subject to adjustment in certain circumstances as set forth in the agreement); and (iii) thereafter, in proportion to the members’ respective percentage interests. Based on these distribution provisions, the Company recognized an equity method loss of $0.52 million related to its investment in IM Topco for each of the three-month periods ended March 31, 2024 and 2023. For cash flow earnings (i.e., net income before intangible asset amortization expense), management allocated the amounts based on the preferences outlined above. As such, Xcel recognized no cash-based earnings for both of the periods presented. For non-cash amortization expense, management allocated the amounts based on the relative ownership of each member (i.e., 70% WHP and 30% Xcel). The equity method loss for each period presented is equal Xcel’s share of amortization expense. Summarized financial information for IM Topco for the three months ended March 31, 2024 and 2023 is as follows: ​ ​ ​ ​ ​ ​ ​ ​      For the three months ended ​ ​ March 31, ($ in thousands) ​ 2024 ​ 2023 Revenues ​ $ 2,752 ​ $ 3,346 Gross profit ​ ​ 2,752 ​ ​ 3,346 Loss from continuing operations ​ ​ (437) ​ ​ (143) Net loss ​ ​ (437) ​ ​ (143) ​ Refer to Notes 10, 11, and 12 for other information regarding the Company’s ongoing relationship with IM Topco. ​ Investment in Orme Live, Inc. In December 2023, the Company contributed $0.15 million of cash to ORME in exchange for a 30% equity ownership interest in ORME. The carrying value of this investment is included within other assets in the Company’s condensed consolidated balance sheets. The Company accounts for its 30% interest in the operations of ORME as a component of other operating costs and expenses under the equity method of accounting. The Company’s proportional share of the operating results of ORME for the three months ended March 31, 2024 was a loss of approximately $0.02 million. Longaberger Licensing, LLC Variable Interest Entity Since 2019, Xcel has been party to a limited liability company agreement with a subsidiary of Hilco Global related to Longaberger Licensing, LLC (“LL”). Hilco Global is the sole Class A Member of LL, and Xcel is the sole Class B Member of LL (each individually a “Member”). Each Member holds a 50% equity ownership interest in LL; however, based on an analysis of the contractual terms and rights contained in the LLC agreement and related agreements, the Company has previously determined that under the applicable accounting standards, LL is a variable interest entity and the Company has effective control over LL. Therefore, as the primary beneficiary, the Company has consolidated LL since 2019, and has recognized the assets, liabilities, revenues, and expenses of LL as part of its consolidated financial statements, along with a noncontrolling interest which represents Hilco Global’s 50% ownership share in LL.

Trademarks and Other Intangibles	3 Months Ended
	Mar. 31, 2024
Trademarks and Other Intangibles [Abstract]
Trademarks and Other Intangibles	3.      Trademarks and Other Intangibles   Trademarks and other intangibles, net consist of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​      Weighted      ​ ​      ​ ​      ​ ​ ​   Average   March 31, 2024 ​   Amortization ​ Gross Carrying ​ Accumulated ​ Net Carrying ($ in thousands) ​ Period ​ Amount ​ Amortization ​ Amount Trademarks (finite-lived)   15 years ​   68,880 ​   28,950 ​   39,930 Copyrights and other intellectual property   8 years ​   429 ​   373 ​   56 Total ​ ​ ​ $ 69,309 ​ $ 29,323 ​ $ 39,986 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​      Weighted      ​ ​      ​ ​      ​ ​ ​   Average   December 31, 2023 ​   Amortization   Gross Carrying ​ Accumulated ​ Net Carrying ($ in thousands) ​ Period ​ Amount ​ Amortization ​ Amount Trademarks (finite-lived)   15 years ​   68,880 ​   27,431 ​   41,449 Copyrights and other intellectual property   8 years ​   429 ​   358 ​   71 Total      ​ $ 69,309 ​ $ 27,789 ​ $ 41,520 ​ Amortization expense for intangible assets was approximately $1.53 million for the three-month period ended March 31, 2024 (the "current quarter") and approximately $1.54 million for the three-month period ended March 31, 2023 (the "prior year quarter").

Significant Contracts and Concentrations	3 Months Ended
	Mar. 31, 2024
Significant Contracts [Abstract]
Significant Contracts and Concentrations	4.      Significant Contracts and Concentrations Qurate Agreements Under the Company’s agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based primarily upon a percentage of net retail sales of certain specified branded merchandise. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes. Net licensing revenue from the Qurate Agreements represents a significant portion of the Company’s total net revenue. Net licensing revenue from the Qurate Agreements totaled $1.61 million and $1.52 million for the current quarter and prior year quarter, respectively, representing approximately 59% and 25% of the Company’s total net revenue for the current quarter and prior year quarter, respectively. As of March 31, 2024 and December 31, 2023, the Company had receivables from Qurate of $1.3 million and $1.5 million, respectively, representing approximately 37% and 43% of the Company’s total net accounts receivable, respectively. ​ Halston Master License On May 15, 2023, the Company, through its wholly owned subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston Brand (the “Halston Master License”) with G-III Apparel Group (“G-III”), an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity kits, and such other product categories as mutually agreed upon. The Halston Master License provided for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to G-III’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. G-III has an option to purchase the Halston Brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach of the Halston Master License in accordance with the terms of the Halston Master License. The Licensor granted G-III a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option. As a result of the upfront cash payment and guaranteed minimum royalties discussed above, the Company has recognized $4.2 million and $4.4 million of deferred revenue contract liabilities on its condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023, respectively. As of December 31, 2023, $0.9 million of the contract liability balance was classified as a current liability and approximately $3.5 million was classified as a long-term liability. As of March 31, 2024, $0.9 million of the contract liability balance was classified as a current liability and approximately $3.3 million was classified as a long-term liability. The balance of the deferred revenue contract liabilities will be recognized ratably as revenue over the next 4.13 years. Net licensing revenue recognized from the Halston Master License was $0.6 million for the current quarter, representing approximately 30% of the Company’s total net revenue for the current quarter.

Leases	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Leases	5. Leases The Company is party to operating leases for real estate, and for certain equipment with a term of 12 months or less. The Company is currently not a party to any finance leases. Lease expense (net of sublease income) included in selling, general and administrative expenses on the Company’s condensed consolidated statements of operations was approximately $0.2 million and $0.4 million for the current quarter and prior year quarter, respectively. Cash paid for amounts included in the measurement of operating lease liabilities was approximately $0.4 million in both the current quarter and prior year quarter. 1333 Broadway The Company has an operating lease for offices located at 1333 Broadway, 10th floor, New York, New York, which commenced on March 1, 2016 and expires on October 30, 2027. The average annual fixed rent over the term of this lease is approximately $1.3 million per year, and the lease requires the Company to pay additional rents related to increases in certain taxes and other costs on the property. On January 26, 2024, the Company (as sublessor) entered into an agreement for the sublease of the offices located at 1333 Broadway to a third-party subtenant through October 30, 2027. The average annual fixed rent over the term of the sublease is approximately $0.8 million per year. As a result of entering into the sublease, the Company recognized a non-cash impairment charge of approximately $1.9 million effective February 29, 2024 (which was determined to be the date of a fundamental change to the use of the 1333 Broadway premises) related to the right-of-use asset. Also in connection with entering into the sublease, the Company recognized a non-cash impairment charge of approximately $0.4 million during the current quarter related to leasehold improvement assets at this location. As of March 31, 2024, the Company’s lease of 1333 Broadway has a remaining lease term of approximately 3.58 years, and the lease liability recorded on the Company’s condensed consolidated balance sheet is measured using a discount rate of 6.25%. 550 Seventh Avenue Effective February 29, 2024, the Company entered into an operating lease for new corporate offices located at 550 Seventh Avenue, 11th floor, New York, New York. This lease commenced in April 2024 and expires in April 2031. The average annual lease cost over the term of this lease is approximately $0.5 million per year. As of March 31, 2024, no right-of-use asset or lease liability was recorded in the Company’s condensed consolidated balance sheet related to this lease, as the lease had not yet commenced. Future Lease Obligations As of March 31, 2024, the maturities of lease obligations were as follows: ​ ​ ​ ​ ​ ​ ​ Amount Year      (in thousands) 2024 (April 1 through December 31) ​ $ 1,164 2025 ​ ​ 1,552 2026 ​   1,552 2027 ​   1,294 Total lease payments ​ ​ 5,562 Less: Discount ​ ​ 590 Present value of lease liabilities ​ ​ 4,972 Current portion of lease liabilities ​ ​ 1,278 Non-current portion of lease liabilities ​ $ 3,694 ​

Debt	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Debt	6. Debt The Company’s net carrying amount of debt was comprised of the following: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31,  ​ December 31,  ​ ($ in thousands)      2024      2023 ​ Term loan debt ​ $ 5,000 ​ $ 5,000 ​ Unamortized deferred finance costs related to term loan debt ​   (253) ​   (279) ​ Total ​   4,747 ​   4,721 ​ Current portion of debt ​   1,000 ​   750 ​ Long-term debt ​ $ 3,747 ​ $ 3,971 ​ ​ On October 19, 2023, H Halston IP, LLC (the “Borrower”), a wholly owned indirect subsidiary of Xcel Brands, Inc., entered into a term loan agreement with Israel Discount Bank of New York (“IDB”). Pursuant to this loan agreement, IDB made a term loan to the Company in the aggregate amount of $5.0 million. The proceeds of this term loan were used to pay fees, costs, and expenses incurred in connection with entering into the loan agreement, and may be used for working capital purposes. Such costs incurred in connection with the borrowing included a commitment fee paid to IDB, plus various legal and other fees. These fees and costs totaling $0.3 million have been deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt, and are being amortized to interest expense over the term of the debt using the effective interest method. ​ In connection with this term loan agreement, the Borrower and H Licensing, LLC (“H Licensing”), a wholly owned subsidiary of Xcel, entered into a security agreement (the “Security Agreement”) in favor of IDB, and Xcel entered into a Membership Interest Pledge Agreement (the “Pledge Agreement”) in favor of IDB. Pursuant to the Security Agreement, the Borrower and H Licensing granted to IDB a security interest in substantially all of their respective assets, other than the trademarks owned by the Borrower and H Licensing, to secure the Borrower’s obligations under the October 2023 loan agreement.  Pursuant to the Pledge Agreement, Xcel granted to IDB a security interest in its membership interests in H Licensing to secure the Borrower’s obligations under the October 2023 loan agreement. ​ The term loan matures on October 19, 2028. Principal on the term loan is payable in quarterly installments of $250,000 on each of January 2, April 1, July 1, and October 1 of each year, commencing on April 1, 2024. The Borrower has the right to prepay all or any portion of the term loan at any time without penalty. ​ As of March 31, 2024, the aggregate remaining principal payments under the term loan were as follows: ​ ​ ​ ​ ​ ​ ​ Amount of ($ in thousands)   Principal Year Ending December 31,       Payment 2024 (April 1 through December 31) ​ $ 750 2025 ​   1,000 2026 ​ ​ 1,000 2027 ​ ​ 1,000 2028 ​   1,250 Total ​ $ 5,000 ​ Interest on the term loan accrues at “Term SOFR” (as defined in the loan agreement as the forward-looking term rate based on secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to one month on the day that is two U.S. Government Securities Business Days prior to the first day of each calendar month) plus 4.25% per annum. Interest on the term loan is payable on the first day of each calendar month. In addition, on October 19, 2023, the Borrower also entered into a swap agreement with IDB, pursuant to which IDB will pay the Borrower Term SOFR plus 4.25% per annum on the notional amount of the swap in exchange for the Borrower paying IDB 9.46% per annum on such notional amount. The term and declining notional amount of the swap agreement is aligned with the amortization of the October 2023 term loan principal amount. The fair value of this swap agreement was immaterial as of March 31, 2024 and December 31, 2023. ​ For the current quarter, the Company incurred interest expense (including both interest paid in cash and the amortization of deferred finance costs) related to term loan debt of approximately $0.15 million, reflecting an effective interest rate of approximately 11.6%. The term loan agreement also contains customary covenants, including reporting requirements, trademark preservation, and certain financial covenants including annual guaranteed minimum royalty ratio, annual fixed charge coverage ratio, and minimum cash balance levels, all as specified and defined in the loan agreement. The Company was in compliance with all applicable covenants under the loan agreement as of and for all periods presented in the financial statements.

Stockholders' Equity	3 Months Ended
	Mar. 31, 2024
Stockholders' Equity Note [Abstract]
Stockholders' Equity	7. Stockholders’ Equity Public Offering and Private Placement Transactions On March 15, 2024, the Company entered into an underwriting agreement with Craig-Hallum Capital Group LLC (the “Representative”), as the representative of the underwriters, relating to a firm commitment underwritten public offering (the “Offering”) of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share. The closing of the Offering occurred on March 19, 2024. The net proceeds to the Company from the sale of the shares, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company, were approximately $1.7 million. Upon closing of the Offering, the Company issued the Representative certain warrants to purchase up to 182,952 shares of common stock (the “Representative’s Warrants”) as compensation, which amount was offset against the proceeds received. The Representative’s Warrants will be exercisable at a per share exercise price of $0.8125. The Representative’s Warrants are exercisable, in whole or in part, during the four and one-half-year period commencing 180 days from the commencement of sales of the shares of common stock in the Offering. In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering. The aggregate number of shares of common stock issued from the Offering and the Private Placement was 3,579,064 shares and the total net proceeds received was approximately $1.9 million. Equity Incentive Plans A total of 4,000,000 shares of common stock are eligible for issuance under the Company’s 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board. In addition, stock-based awards (including options, warrants, and restricted stock) previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options or warrants previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan. Stock-based Compensation The Company accounts for stock-based compensation by recognizing the fair value of such compensation as an operating expense over the service period of the award or term of the corresponding contract, as applicable. Forfeitures are accounted for as a reduction of compensation cost in the period when such forfeitures occur. For stock option awards for which vesting is contingent upon the achievement of certain performance targets, the timing and amount of compensation expense recognized is based upon the Company’s projections and estimates of the relevant performance metric(s) until the time the performance obligation is satisfied. Expense for such awards is recognized only to the extent that the achievement of the specified performance target(s) has been met or is considered probable. Total expense recognized for all forms of stock-based compensation was approximately $0.13 million and $0.06 million for the current quarter and prior year quarter, respectively. For both periods, substantially all of the expense was related to directors and consultants, and was recorded as operating costs within “other selling, general and administrative expenses” in the accompanying condensed consolidated statements of operations. Stock Options A summary of the Company’s stock options activity for the current quarter is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Average ​ ​ ​ ​ ​ ​ ​ Weighted ​ Remaining ​ ​ ​ ​ ​ ​ ​ Average ​ Contractual ​ Aggregate ​ ​ Number of ​ Exercise ​ Life ​ Intrinsic ​      Options      Price      (in Years)      Value Outstanding at January 1, 2024   5,148,540 ​ $ 2.03   4.26 ​ $ — Granted   — ​   —      ​      Exercised   — ​   —      ​      Expired/Forfeited   (259,500) ​   4.21      ​      Outstanding at March 31, 2024, and expected to vest   4,889,040 ​ $ 1.91   4.24 ​ $ — Exercisable at March 31, 2024   1,139,040 ​ $ 2.58   1.78 ​ $ — ​ Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $0.02 million and $0.03 million, respectively. Total unrecognized compensation expense related to unvested stock options at March 31, 2024 was approximately $0.05 million and is expected to be recognized over a weighted average period of approximately 0.97 years. A summary of the Company’s non-vested stock options activity for the current quarter is as follows: ​ ​ ​ ​ ​ ​ ​ ​      ​      Weighted ​ ​ ​ ​  Average  ​ ​ Number of ​ Grant Date  ​      Options      Fair Value Balance at January 1, 2024   3,750,000 ​ $ 0.05 Granted   — ​   — Vested   — ​ ​ — Forfeited or Canceled   — ​   — Balance at March 31, 2024   3,750,000 ​ $ 0.05 ​ ​ Stock Awards A summary of the Company’s restricted stock activity for the current quarter is as follows:   ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ Number of ​ Average ​ ​ Restricted ​ Grant Date ​      Shares      Fair Value Outstanding at January 1, 2024   333,333 ​ $ 3.69 Granted   78,000 ​   1.25 Vested   (78,000) ​   1.25 Expired/Forfeited   — ​   — Outstanding at March 31, 2024   333,333 ​ $ 3.69 ​ On January 12, 2024, the Company issued 78,000 shares of common stock to a consultant, which shares vested immediately. Compensation expense related to stock awards was approximately $0.11 million for the current quarter and approximately $0.03 million for the prior year quarter. Total unrecognized compensation expense related to unvested restricted stock grants at March 31, 2024 was approximately $0.04 million and is expected to be recognized over a weighted average period of approximately 0.96 years. Restricted Stock Units There were no restricted stock units outstanding as of March 31, 2024 and December 31, 2023, and no restricted stock units have been issued since the inception of the 2021 Plan. Shares Available Under the Company’s Equity Incentive Plans At March 31, 2024, there were 3,025,941 shares of common stock available for future award grants under the 2021 Plan. Shares Reserved for Issuance As of March 31, 2024, there were 8,031,046 shares of common stock reserved for issuance, including 4,511,755 shares reserved pursuant to unexercised warrants and stock options previously granted under the 2011 Plan, 493,350 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 3,025,941 shares available for issuance under the 2021 Plan. ​ ​ Warrants A summary of the Company’s warrants activity for the current quarter is as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Average ​ ​ ​ ​ ​ ​ ​ Weighted ​ Remaining ​ ​ ​ ​ ​ ​   Average   Contractual ​ Aggregate ​ ​ Number of ​ Exercise   Life ​ Intrinsic ​      Warrants      Price      (in Years)      Value Outstanding and exercisable at January 1, 2024   1,116,065 ​ $ 1.67   8.46 ​ $ — Issued   182,952 ​   0.81   ​ ​      Exercised   — ​   —   ​ ​      Expired/Forfeited   — ​   —   ​ ​      Outstanding at March 31, 2024   1,299,017 ​ $ 1.55   7.75 ​ $ — Exercisable at March 31, 2024   116,065 ​ $ 3.15   0.30 ​ $ — ​ Warrants issued during the current quarter were related to the March 19, 2024 Offering (see “Public Offering and Private Placement Transactions” above for details). There was no compensation expense recognized during the current quarter related to these warrants. In connection with the entrance into the Halston Master License (see Note 4), the Company issued to G-III a ten-year warrant to purchase up to 1,000,000 shares of the Company’s common stock at an exercise price of $1.50 per share, which vests based upon certain annual royalty targets being satisfied under the license agreement. The fair value of this warrant is being recognized as a reduction of revenue over the term of the related license agreement, with an offsetting increase to stockholders’ equity as additional paid-in capital. The amount of contra-revenue recorded related to this warrant during the current quarter was approximately $0.01 million. As of March 31, 2024, no portion of this warrant had vested. Excluding the contra-revenue recognized with respect to the Halston Master License warrant, there was no compensation expense related to warrants recognized in the current quarter or prior year quarter.

Earnings (Loss) Per Share	3 Months Ended
	Mar. 31, 2024
Earnings (Loss) Per Share [Abstract]
Earnings (Loss) Per Share	8.    Earnings (Loss) Per Share Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS reflects, in periods in which they have a dilutive effect, the effect of common shares issuable upon the exercise of stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive. ​ The following table is a reconciliation of the numerator and denominator of the basic and diluted net loss per share computations for the three months ended March 31, 2024 and 2023: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ ​ ​ March 31,  ​ ​      2024      2023 ​ Numerator: ​ ​ ​ ​ ​ ​ ​ Net loss attributable to Xcel Brands, Inc. stockholders (in thousands) ​ $ (6,294) ​ $ (5,643) ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ Basic weighted average number of shares outstanding ​ ​ 20,374,920   ​ 19,633,194   Add: Effect of warrants ​ ​ —   ​ —   Add: Effect of stock options ​ ​ — ​ ​ — ​ Diluted weighted average number of shares outstanding ​ ​ 20,374,920   ​ 19,633,194 ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic net loss per share ​ $ (0.31) ​ $ (0.29) ​ Diluted net loss per share ​ $ (0.31) ​ $ (0.29) ​ ​ As a result of the net loss for the current quarter and prior year quarter, the Company calculated diluted EPS using basic weighted average shares outstanding for such periods, as utilizing diluted shares would be anti-dilutive to loss per share for such periods. ​ The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:   ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ ​ ​ March 31,  ​ ​      2024      2023 ​ Stock options ​ 4,889,040 ​ 5,368,780 ​ Warrants ​ 1,299,017 ​ 116,065 ​ Total ​ 6,188,057   5,484,845   ​

Income Taxes	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	9.    Income Taxes The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately 0% for both periods, resulting in an income tax benefit of $0 for both periods. For both the current quarter and the prior year quarter, the federal statutory rate differed from the effective tax rate due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

Related Party Transactions	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	​ ​ 10.    Related Party Transactions IM Topco, LLC As described in Note 2, the Company holds a noncontrolling interest in IM Topco, which is accounted for under the equity method of accounting. Service Agreement On May 31, 2022, the Company entered into a services agreement with IM Topco, pursuant to which the Company provides certain design and support services (including assistance with the operations of the interactive television business and related talent support) to IM Topco in exchange for payments of $300,000 per year. ​ In November 2023, the services agreement was amended such that the Company agreed to provide IM Topco with a $600,000 reduction of future service fees over the next eighteen months, beginning on July 1, 2023. ​ The Company recognized service fee income related to this agreement of $37,500 and $75,000 for the current quarter and prior year quarter, respectively. ​ License Agreement ​ On May 31, 2022, the Company entered into a license agreement with IM Topco, pursuant to which IM Topco granted the Company a license to use certain Isaac Mizrahi trademarks on and in connection with the design, manufacture, distribution, sale, and promotion of women’s sportswear products in the United States and Canada during the term of the agreement, in exchange for the payment of royalties in connection therewith. The initial term of this agreement was set to end on December 31, 2026, and provided guaranteed minimum royalties to IM Topco of $400,000 per year. ​ Effective December 16, 2022, the license agreement between IM Topco and Xcel was terminated in favor of a new similar license agreement between IM Topco and an unrelated third party. However, as part of the termination of the May 31, 2022 license agreement, Xcel provided a guarantee to IM Topco for the payment of any difference between (i) the royalties received by IM Topco from the unrelated third party under the new agreement and (ii) the amount of guaranteed royalties that IM Topco would have received from Xcel under the May 31, 2022 agreement. For the prior year quarter, the estimated amount of such shortfall was approximately $60,000, which the Company recognized as royalty expense in the condensed consolidated statements of operations. ​ In November 2023, the Company, WHP, and IM Topco entered into an amendment of the May 27, 2022 membership purchase agreement, under which Xcel agreed to make additional royalty payments to IM Topco totaling $450,000 over the next 11 months. As a result of this amendment, the Company recognized a $450,000 increase to the carrying value basis of its equity method investment in IM Topco and a corresponding increase in current liabilities. No amounts were paid to IM Topco during the current quarter, and as of March 31, 2024, the remaining payments due totaled $375,000. ​ Financing Transactions ​ Public Offering and Private Placement Transactions ​ In connection with the Offering of 3,284,422 shares of the Company’s common stock at a price to the public of $0.65 per share which was consummated on March 19, 2024 (see Note 7 for additional details), Robert W. D’Loren, Chairman and Chief Executive Officer of the Company; an affiliate of Mark DiSanto, a director of the Company; and Seth Burroughs, Executive Vice President of Business Development and Treasury of the Company, purchased 146,250, 146,250, and 32,500 shares, respectively, at $0.65 per share, the same price at which the shares were sold to other purchasers in the Offering. In connection with the Offering, on March 14, 2024, the Company entered into subscription agreements with each of Mr. D’Loren, Mr. DiSanto, and Mr. Burroughs to purchase 132,589, 132,589, and 29,464 shares, respectively (collectively, the “Private Placement Shares”), at a price of $0.98 per Private Placement Share. The total number of Private Placement Shares purchased was 294,642. Net proceeds after payment of agent fees to the Representative were approximately $0.3 million. The purchase of the Private Placement Shares closed concurrently with the Offering. ​

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	11.    Commitments and Contingencies Contingent Obligation – Isaac Mizrahi Transaction In connection with the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi Brand, the Company agreed with WHP that, in the event that IM Topco receives less than $13.3 million in aggregate royalties for any four consecutive calendar quarters over a three-year period ending on May 31, 2025, WHP would be entitled to receive from Xcel up to $16 million, less all amounts of net cash flow distributed to WHP on an accumulated basis, as an adjustment to the purchase price previously paid by WHP. Such amount would be payable by the Company in either cash or equity interests in IM Topco held by the Company. In November 2023, this agreement was amended such that the purchase price adjustment provision was waived until the measurement period ending March 31, 2024. The purchase price adjustment provision was subsequently further amended in April 2024 (see Note 12 for details). No amount has been recorded in the accompanying condensed consolidated balance sheets related to this contingent obligation. Contingent Obligation – Lori Goldstein Earn-Out In connection with the April 1, 2021 purchase of the Lori Goldstein trademarks, the Company agreed to pay the seller additional cash consideration (the “Lori Goldstein Earn-Out”) of up to $12.5 million, based on royalties earned during the six calendar year period commencing in 2021. The Lori Goldstein Earn-Out was initially recorded as a liability of $6.6 million, based on the difference between the fair value of the acquired assets of the Lori Goldstein brand and the total consideration paid, in accordance with the guidance in ASC Subtopic 805-50. As of December 31, 2022, based on the performance of the Lori Goldstein brand to date, approximately $0.2 million of additional consideration was earned by the seller, and this $0.2 million of additional consideration was paid to the seller during 2023. Based on the performance of the Lori Goldstein through December 31, 2023, approximately $1.0 million of incremental additional consideration was earned by the seller, which will be paid out in 2024. During the current quarter, the Company paid approximately $0.3 million of the $1.0 million earned, and as of March 31, 2024, $0.7 million of the remaining balance was recorded as a current liability and $5.4 million was recorded as a long-term liability. Legal Matters From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable. ​ With the exception of the matter described in detail below, in the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows. ​ On February 16, 2024, counsel to Lori Goldstein, a brand spokesperson for the Company, advised the Company that the Company was in material breach of the Asset Purchase Agreement dated March 31, 2021 (the “Asset Purchase Agreement”) by and among Gold Licensing LLC (“Gold” and, together with Xcel, the ”Xcel Parties”), a subsidiary of the Company, and Lori Goldstein and Lori Goldstein, Ltd. (“LG Ltd” and, together with Lori Goldstein, the “LG Parties”) for failure to pay $963,642 earned in 2023 in accordance with the earn-out provisions of the agreement. The Company does not dispute the amount of the Lori Goldstein Earn-Out that was achieved in 2023, and advised Ms. Goldstein that due to the alleged breaches described below, the Company was not willing to pay this amount at such time. The Company subsequently paid approximately $241,000 of the earn-out payment. ​ On May 2, 2024, the Xcel Parties made a written demand for arbitration and commenced an arbitration proceeding against the LG Parties for, among other things, alleged breaches of the Asset Purchase Agreement and alleged breaches of Ms. Goldstein’s employment agreement with the Company. The Company is seeking compensatory damages and consequential damages. Additionally, on May 2, 2024, the Company terminated the employment agreement and the consulting agreement between the Company and LG Ltd. The parties are negotiating to resolve all outstanding disputes and, if an agreement is reached, it may include, among other things, a disposition of the Lori Goldstein brands and related assets to LG Ltd. By agreement between the Company and Ms. Goldstein, while negotiations continue, Ms. Goldstein is continuing to comply with her material obligations to QVC. There can be no assurance that these disputes will be resolved in a manner favorable to the Company or at all. ​ As of the filing date of this Quarterly Report on Form 10-Q, there have been no definitive agreements or terms agreed to by the parties, and it is not certain when or if an agreement will be executed.

Subsequent Events	3 Months Ended
	Mar. 31, 2024
Subsequent Event
Subsequent Events	12.    Subsequent Events IM Topco On April 12, 2024, the Company, WHP, and IM Topco entered into amendments of the May 27, 2022 (and as subsequently amended) membership purchase agreement and the related business venture agreement. Under these amendments, the parties agreed to the following: ● The purchase price adjustment provision within the membership purchase agreement was waived until the measurement period ending September 30, 2025. ● If IM Topco royalties are less than $13.5 million for the twelve-month period ending March 31, 2025 or less than $18.0 million for the year ending December 31, 2025, Xcel shall transfer equity interests in IM Topco to WHP equal to 12.5% of the total outstanding equity interests of IM Topco, such that Xcel’s ownership interest in IM Topco would decrease from 30% to 17.5%, and WHP’s ownership interest in IM Topco would increase from 70% to 82.5%. In addition, Xcel shall be obligated to make such transfer to WHP if Xcel fails to make certain payments owed to IM Topco by October 10, 2024 under the second amendment (which totaled $375,000 as of December 31, 2023 and March 31, 2024). In April 2024, Xcel paid $100,000 of this amount to WHP. ● On and after January 1, 2026, WHP shall receive 50% of the Net Cash Flow which would otherwise be payable to Xcel, until WHP has received an aggregate amount of additional Net Cash Flow equal to $1.0 million.

Investments in Unconsolidated Affiliates and Variable Interest Entities (Tables)	3 Months Ended
	Mar. 31, 2024
Acquisitions, Divestitures and Variable Interest Entities[Abstract]
Summarized financial information for IM Topco	Summarized financial information for IM Topco for the three months ended March 31, 2024 and 2023 is as follows: ​ ​ ​ ​ ​ ​ ​ ​      For the three months ended ​ ​ March 31, ($ in thousands) ​ 2024 ​ 2023 Revenues ​ $ 2,752 ​ $ 3,346 Gross profit ​ ​ 2,752 ​ ​ 3,346 Loss from continuing operations ​ ​ (437) ​ ​ (143) Net loss ​ ​ (437) ​ ​ (143)

Trademarks and Other Intangibles (Tables)	3 Months Ended
	Mar. 31, 2024
Trademarks and Other Intangibles [Abstract]
Schedule of Trademarks and Other Intangibles	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​      Weighted      ​ ​      ​ ​      ​ ​ ​   Average   March 31, 2024 ​   Amortization ​ Gross Carrying ​ Accumulated ​ Net Carrying ($ in thousands) ​ Period ​ Amount ​ Amortization ​ Amount Trademarks (finite-lived)   15 years ​   68,880 ​   28,950 ​   39,930 Copyrights and other intellectual property   8 years ​   429 ​   373 ​   56 Total ​ ​ ​ $ 69,309 ​ $ 29,323 ​ $ 39,986 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​      Weighted      ​ ​      ​ ​      ​ ​ ​   Average   December 31, 2023 ​   Amortization   Gross Carrying ​ Accumulated ​ Net Carrying ($ in thousands) ​ Period ​ Amount ​ Amortization ​ Amount Trademarks (finite-lived)   15 years ​   68,880 ​   27,431 ​   41,449 Copyrights and other intellectual property   8 years ​   429 ​   358 ​   71 Total      ​ $ 69,309 ​ $ 27,789 ​ $ 41,520 ​

Leases (Tables)	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Maturities of Lease Liabilities	​ ​ ​ ​ ​ ​ ​ Amount Year      (in thousands) 2024 (April 1 through December 31) ​ $ 1,164 2025 ​ ​ 1,552 2026 ​   1,552 2027 ​   1,294 Total lease payments ​ ​ 5,562 Less: Discount ​ ​ 590 Present value of lease liabilities ​ ​ 4,972 Current portion of lease liabilities ​ ​ 1,278 Non-current portion of lease liabilities ​ $ 3,694 ​

Debt (Tables)	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Schedule of Debt	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ March 31,  ​ December 31,  ​ ($ in thousands)      2024      2023 ​ Term loan debt ​ $ 5,000 ​ $ 5,000 ​ Unamortized deferred finance costs related to term loan debt ​   (253) ​   (279) ​ Total ​   4,747 ​   4,721 ​ Current portion of debt ​   1,000 ​   750 ​ Long-term debt ​ $ 3,747 ​ $ 3,971 ​
Schedule of Maturities of Long-Term Debt	​ ​ ​ ​ ​ ​ ​ Amount of ($ in thousands)   Principal Year Ending December 31,       Payment 2024 (April 1 through December 31) ​ $ 750 2025 ​   1,000 2026 ​ ​ 1,000 2027 ​ ​ 1,000 2028 ​   1,250 Total ​ $ 5,000

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2024
Stockholders' Equity Note [Abstract]
Summary of Stock Option Activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Average ​ ​ ​ ​ ​ ​ ​ Weighted ​ Remaining ​ ​ ​ ​ ​ ​ ​ Average ​ Contractual ​ Aggregate ​ ​ Number of ​ Exercise ​ Life ​ Intrinsic ​      Options      Price      (in Years)      Value Outstanding at January 1, 2024   5,148,540 ​ $ 2.03   4.26 ​ $ — Granted   — ​   —      ​      Exercised   — ​   —      ​      Expired/Forfeited   (259,500) ​   4.21      ​      Outstanding at March 31, 2024, and expected to vest   4,889,040 ​ $ 1.91   4.24 ​ $ — Exercisable at March 31, 2024   1,139,040 ​ $ 2.58   1.78 ​ $ —
Summary of Stock Option Activity for Non-Vested Options	​ ​ ​ ​ ​ ​ ​ ​      ​      Weighted ​ ​ ​ ​  Average  ​ ​ Number of ​ Grant Date  ​      Options      Fair Value Balance at January 1, 2024   3,750,000 ​ $ 0.05 Granted   — ​   — Vested   — ​ ​ — Forfeited or Canceled   — ​   — Balance at March 31, 2024   3,750,000 ​ $ 0.05
Summary of Restricted Stock Activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ Number of ​ Average ​ ​ Restricted ​ Grant Date ​      Shares      Fair Value Outstanding at January 1, 2024   333,333 ​ $ 3.69 Granted   78,000 ​   1.25 Vested   (78,000) ​   1.25 Expired/Forfeited   — ​   — Outstanding at March 31, 2024   333,333 ​ $ 3.69
Summary of Warrant Activity	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Weighted ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Average ​ ​ ​ ​ ​ ​ ​ Weighted ​ Remaining ​ ​ ​ ​ ​ ​   Average   Contractual ​ Aggregate ​ ​ Number of ​ Exercise   Life ​ Intrinsic ​      Warrants      Price      (in Years)      Value Outstanding and exercisable at January 1, 2024   1,116,065 ​ $ 1.67   8.46 ​ $ — Issued   182,952 ​   0.81   ​ ​      Exercised   — ​   —   ​ ​      Expired/Forfeited   — ​   —   ​ ​      Outstanding at March 31, 2024   1,299,017 ​ $ 1.55   7.75 ​ $ — Exercisable at March 31, 2024   116,065 ​ $ 3.15   0.30 ​ $ —

Earnings (Loss) Per Share (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings (Loss) Per Share [Abstract]
Schedule of the basic and diluted net loss per share	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ ​ ​ March 31,  ​ ​      2024      2023 ​ Numerator: ​ ​ ​ ​ ​ ​ ​ Net loss attributable to Xcel Brands, Inc. stockholders (in thousands) ​ $ (6,294) ​ $ (5,643) ​ ​ ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ ​ ​ ​ ​ ​ Basic weighted average number of shares outstanding ​ ​ 20,374,920   ​ 19,633,194   Add: Effect of warrants ​ ​ —   ​ —   Add: Effect of stock options ​ ​ — ​ ​ — ​ Diluted weighted average number of shares outstanding ​ ​ 20,374,920   ​ 19,633,194 ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic net loss per share ​ $ (0.31) ​ $ (0.29) ​ Diluted net loss per share ​ $ (0.31) ​ $ (0.29) ​
Anti-dilutive Securities Excluded from Computation of Earnings (Loss) Per Share	​ ​ ​ ​ ​ ​ ​ ​ ​ Three Months Ended ​ ​ ​ March 31,  ​ ​      2024      2023 ​ Stock options ​ 4,889,040 ​ 5,368,780 ​ Warrants ​ 1,299,017 ​ 116,065 ​ Total ​ 6,188,057   5,484,845   ​

Nature of Operations, Background, and Basis of Presentation (Details)	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	May 31, 2022
Longaberger Licensing, LLC | Variable Interest Entity, Primary Beneficiary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage	50.00%
IM Topco, LLC
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Ownership interest	30.00%		30.00%
ORME
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Ownership interest	30.00%	30.00%

Nature of Operations, Background, and Basis of Presentation - Liquidity and Management's Plans (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Nature of Operations, Background, and Basis of Presentation [Abstract]
Net Income (Loss)		$ (6,294)	$ (5,643)
Non-cash expenses		4,600
Accumulated deficit	$ (60,143)	(60,143)		$ (53,849)
Net cash used in operating activities		(2,609)	(2,915)
Working capital, Net	2,100	2,100
Cash and cash equivalents	2,291	2,291	$ 1,612	2,998	$ 4,608
Restricted cash	739	739
Reduction in payroll costs				6,000
Reduction in operating expenses				9,000
Term loan debt	5,000	5,000		$ 5,000
Proceeds from public offering and private placement transactions, net of transaction costs	$ 1,900	$ 1,902

Investments in Unconsolidated Affiliates and Variable Interest Entities - Sale of Majority Interest in Isaac Mizrahi Brand, Investment in IM Topco, LLC (Details) - USD ($)		3 Months Ended
	May 31, 2022	Mar. 31, 2024	Sep. 30, 2023	Mar. 31, 2023	May 27, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss from equity method investment		$ (533,000)		$ (515,000)
IM Topco, LLC
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Ownership interest	30.00%	30.00%
IM Topco, LLC
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss from equity method investment			$ (520,000)
Business Venture Agreement
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net cash flow distributable to members (in percent)	100.00%
Net cash flow distributable to members	$ 1,316,200
Business Venture Agreement | WHP
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net cash flow distributable to members (in percent)	100.00%
Net cash flow distributable to members	$ 8,852,000
IM Brand trademarks and other intellectual property rights | Disposed of by Sale | IM Topco, LLC
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Ownership interest		70.00%			70.00%

Investments in Unconsolidated Affiliates and Variable Interest Entities - Summarized financial information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gross Profit	$ 2,184	$ 3,357
Net (loss) income	(6,345)	(5,938)
IM Topco, LLC
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	2,752	3,346
Gross Profit	2,752	3,346
(Loss) income from continuing operations	(437)	(143)
Net (loss) income	$ (437)	$ (143)

Investments in Unconsolidated Affiliates and Variable Interest Entities - Investment in Orme Live, Inc. (Details) - ORME - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	Dec. 31, 2023	Mar. 31, 2024
Schedule Of Asset Acquisition [Line Items]
Members contribution	$ 150
Ownership interest	30.00%	30.00%
Proportional share of the operating results		$ 20

Investments in Unconsolidated Affiliates and Variable Interest Entities - Longaberger Licensing, LLC VIE (Details) - Longaberger Licensing, LLC - Variable Interest Entity, Primary Beneficiary	3 Months Ended
	Mar. 31, 2024
Schedule Of Asset Acquisition [Line Items]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage	50.00%
Hilco Global
Schedule Of Asset Acquisition [Line Items]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage	50.00%

Trademarks and Other Intangibles - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Trademarks and Other Intangibles [Abstract]
Amortization expense for intangible assets	$ 1,530	$ 1,540

Trademarks and Other Intangibles - Schedule of Trademarks and Other Intangibles (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Trademarks and Other Intangibles
Gross Carrying Amount	$ 69,309	$ 69,309
Accumulated Amortization	29,323	$ 27,789
Total	$ 39,986
Trademarks (finite-lived)
Trademarks and Other Intangibles
Weighted Average Amortization Period	15 years	15 years
Gross Carrying Amount	$ 68,880	$ 68,880
Accumulated Amortization	28,950	27,431
Total	$ 39,930	$ 41,449
Copyrights and other intellectual property
Trademarks and Other Intangibles
Weighted Average Amortization Period	8 years	8 years
Gross Carrying Amount	$ 429	$ 429
Accumulated Amortization	373	358
Total	$ 56	$ 71

Significant Contracts - Qurate Agreements (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Product Information [Line Items]
Net revenue	$ 2,184	$ 6,050
Accounts receivable	3,603		$ 3,454
Net licensing revenue
Product Information [Line Items]
Net revenue	$ 2,184	$ 2,222
Sales [Member] | Customer Concentration Risk [Member] | Qurate
Product Information [Line Items]
Concentration Risk, Percentage	59.00%	25.00%
Sales [Member] | Customer Concentration Risk [Member] | Qurate | Net licensing revenue
Product Information [Line Items]
Net revenue	$ 1,610	$ 1,520
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Qurate
Product Information [Line Items]
Concentration Risk, Percentage	37.00%		43.00%
Accounts receivable	$ 1,300		$ 1,500

Significant Contracts - Halson Master License (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	May 15, 2023	Mar. 31, 2024	Mar. 31, 2023	Mar. 19, 2024	Dec. 31, 2023
Subsequent Event [Line Items]
Purchaseable stock		23,452,117			19,795,053
Deferred revenue, current		$ 889			$ 889
Deferred revenue, long-term liability		3,333			3,556
Licensing revenue		2,184	$ 6,050
Contra-revenue related to warrants granted to licensee		$ 10
Sales [Member] | Customer Concentration Risk [Member] | Halston License
Subsequent Event [Line Items]
Concentration risk, percentage		30.00%
Warrants
Subsequent Event [Line Items]
Warrant term				4 years 6 months
Purchaseable stock				182,952
Warrants outstanding, exercise price (in dollars per share)				$ 0.8125
Net licensing revenue
Subsequent Event [Line Items]
Licensing revenue		$ 2,184	$ 2,222
Halston License
Subsequent Event [Line Items]
Additional royalty payable term	20 years
Total purchase price	$ 5,000
Deferred revenue		4,200			4,400
Deferred revenue, current		900			900
Deferred revenue, long-term liability		$ 3,300			$ 3,500
Recognition period of deferred revenue		4 years 1 month 17 days
Licensing revenue		$ 600
Halston License | Minimum
Subsequent Event [Line Items]
Royalty payable term	5 years
Halston License | Maximum
Subsequent Event [Line Items]
Royalty payable term	25 years

Leases - Narrative (Details) - USD ($) $ in Millions			3 Months Ended
	Feb. 29, 2024	Jan. 26, 2024	Mar. 31, 2024	Mar. 31, 2023
Lessee, Lease, Description [Line Items]
Lease expiration date			Oct. 30, 2027
Cash payments for operating lease expense			$ 0.4	$ 0.4
Weighted average discount rate			6.25%
Weighted average remaining lease term for operating leases			3 years 6 months 29 days
1333 Broadway
Lessee, Lease, Description [Line Items]
Annual fixed rent amount			$ 1.3
Annual fixed sublease rent amount		$ 0.8
1333 Broadway | Right-of-use assets
Lessee, Lease, Description [Line Items]
Non-cash impairment charge	$ 1.9
1333 Broadway | Leasehold improvements
Lessee, Lease, Description [Line Items]
Non-cash impairment charge			0.4
530 Seventh Avenue
Lessee, Lease, Description [Line Items]
Annual fixed rent amount	$ 0.5
Selling, general and administrative expenses
Lessee, Lease, Description [Line Items]
Operating lease expense			$ 0.2	$ 0.4

Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Leases [Abstract]
2024 (April 1 through December 31)	$ 1,164
2025	1,552
2026	1,552
2027	1,294
Total lease payments	5,562
Less: Discount	590
Present value of lease liabilities	4,972
Current portion of lease liabilities	1,278	$ 1,258
Non-current portion of lease liabilities	$ 3,694	$ 4,021

Debt - Narrative (Details) - USD ($)		3 Months Ended
	Oct. 19, 2023	Mar. 31, 2024	Dec. 31, 2023
Debt
Term loan debt		$ 5,000,000	$ 5,000,000
Unamortized deferred finance costs related to term loan debt		253,000	$ 279,000
Interest expense		$ 146,000
Effective interest rate (as percentage)		11.60%
Swap contract with IDB
Debt
Derivative, fixed interest rate	9.46%
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Swap contract with IDB | IDB
Debt
Derivative, basis spread on variable rate	4.25%
New Loan Agreement
Debt
Term loan debt	$ 5,000,000.0	$ 5,000,000
Unamortized deferred finance costs related to term loan debt	300,000
Quarterly installment amount	$ 250,000
New Loan Agreement | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt
Stated interest rate (as percentage)	4.25%

Debt - Net Carrying Amount of Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Disclosure [Abstract]
Term loan debt	$ 5,000	$ 5,000
Unamortized deferred finance costs related to term loan debt	(253)	(279)
Total	4,747	4,721
Current portion of debt	1,000	750
Long-term debt	$ 3,747	$ 3,971

Debt - Xcel Term Loan Remaining Principal Payments (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Oct. 19, 2023
Debt
Total	$ 5,000	$ 5,000
New Loan Agreement
Debt
2024 (April 1 through December 31)	750
2025	1,000
2026	1,000
2027	1,000
2028	1,250
Total	$ 5,000		$ 5,000

Stockholders' Equity - Public Offering and Private Placement Transactions (Details) - USD ($) $ / shares in Units, $ in Thousands				1 Months Ended	3 Months Ended
	Mar. 19, 2024	Mar. 15, 2024	Mar. 14, 2024	Mar. 31, 2024	Mar. 31, 2024	Dec. 31, 2023
Class of Stock [Line Items]
Purchaseable stock				23,452,117	23,452,117	19,795,053
Common stock issued				23,452,117	23,452,117	19,795,053
Proceeds from public offering and private placement transactions, net of transaction costs				$ 1,900	$ 1,902
Warrants
Class of Stock [Line Items]
Purchaseable stock	182,952
Warrants outstanding, exercise price (in dollars per share)	$ 0.8125
Warrant term	4 years 6 months
Public Offering and Private Placement
Class of Stock [Line Items]
Common stock issued		3,579,064
Proceeds from public offering and private placement transactions, net of transaction costs		$ 1,900			$ 1,902
Public Offering
Class of Stock [Line Items]
Purchaseable stock	3,284,422	3,284,422
Common stock price	$ 0.65	$ 0.65
Net proceeds from the sale of shares	$ 1,700
Public Offering | Chief Executive Officer
Class of Stock [Line Items]
Common stock issued	146,250
Public Offering | Director
Class of Stock [Line Items]
Common stock issued	146,250
Public Offering | Executive Vice President
Class of Stock [Line Items]
Common stock issued	32,500
Private Placement
Class of Stock [Line Items]
Common stock price			$ 0.98
Net proceeds from the sale of private placement shares			$ 300
Private Placement | Agreements
Class of Stock [Line Items]
Common stock issued			294,642
Private Placement | Chief Executive Officer
Class of Stock [Line Items]
Common stock issued			132,589
Private Placement | Director
Class of Stock [Line Items]
Common stock issued			132,589
Private Placement | Executive Vice President
Class of Stock [Line Items]
Common stock issued			29,464

Stockholders' Equity - Equity Incentive Plans (Details)	Mar. 31, 2024 shares
Stockholders' Equity
Shares of common stock reserved for issuance (in shares)	8,031,046
2011 Equity Incentive Plan | Unexercised Stock Options
Stockholders' Equity
Shares of common stock reserved for issuance (in shares)	4,511,755
2021 Equity Incentive Plan
Stockholders' Equity
Number of common stock eligible for issuance	4,000,000
Shares are granted available for issuance (in shares)	3,025,941
Shares of common stock reserved for issuance (in shares)	3,025,941
2021 Equity Incentive Plan | Unexercised Stock Options
Stockholders' Equity
Shares of common stock reserved for issuance (in shares)	493,350

Stockholders' Equity - Stock-based Compensation (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Stockholders' Equity Note [Abstract]
Compensation expense	$ 130	$ 60

Stockholders' Equity - Stock Options (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Other disclosures
Compensation expense	$ 130,000	$ 60,000.00
Employee Stock Option [Member]
Number of Options
Outstanding, beginning balance (in shares)	5,148,540
Granted (in shares)	0
Exercised (in shares)	0
Expired/Forfeited (in shares)	(259,500)
Outstanding, ending balance (in shares)	4,889,040		5,148,540
Exercisable (in shares)	1,139,040
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share)	$ 2.03
Granted (in dollars per share)	0
Exercised (in dollars per share)	0
Expired/Forfeited (in dollars per share)	4.21
Outstanding, ending balance (in dollars per share)	1.91		$ 2.03
Exercisable (in dollars per share)	$ 2.58
Other disclosures
Outstanding Weighted Average Remaining Contractual Life (in Years)	4 years 2 months 26 days		4 years 3 months 3 days
Exercisable Weighted Average Remaining Contractual Life (in Years)	1 year 9 months 10 days
Aggregate Intrinsic Value, Outstanding	$ 0		$ 0
Aggregate Intrinsic Value, Exercisable	0
Compensation expense	20,000.00	$ 30,000.00
Unrecognized compensation expense	$ 50,000.00
Weighted average period of recognition	11 months 19 days

Stockholders' Equity - Non-Vested Options (Details) - Employee Stock Option [Member]	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Number of Options
Beginning Balance (in shares) | shares	3,750,000
Ending Balance (in shares) | shares	3,750,000
Weighted Average Grant Date Fair Value
Beginning Balance (in dollars per share) | $ / shares	$ 0.05
Ending Balance (in dollars per share) | $ / shares	$ 0.05

Stockholders' Equity - Stock Awards (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Jan. 12, 2024	Mar. 31, 2024	Mar. 31, 2023
Other disclosures
Compensation expense		$ 130	$ 60
Consultant
Number of Other than Options
Granted (in shares)	78,000
Restricted Stock
Number of Other than Options
Outstanding, beginning balance (in shares)		333,333
Granted (in shares)		78,000
Vested (in shares)		(78,000)
Expired/Forfeited (in shares)		0
Outstanding, ending balance (in shares)		333,333
Weighted Average Exercise Price
Outstanding, beginning balance (in dollars per share)		$ 3.69
Granted (in dollars per share)		1.25
Vested (in dollars per share)		1.25
Expired/Forfeited (in dollars per share)		0
Outstanding, ending balance (in dollars per share)		$ 3.69
Other disclosures
Unrecognized compensation expense		$ 40
Weighted average period of recognition		11 months 15 days
Common Stock
Other disclosures
Compensation expense		$ 110	$ 30

Stockholders' Equity - Restricted Stock Units (Details) - shares	Mar. 31, 2024	Dec. 31, 2023
Stockholders' Equity
Common stock, shares outstanding (in shares)	23,452,117	19,795,053
Common stock, shares issued (in shares)	23,452,117	19,795,053
Restricted Stock
Stockholders' Equity
Common stock, shares outstanding (in shares)	0	0
Common stock, shares issued (in shares)	0	0

Stockholders' Equity - Warrants (Details) - USD ($)		3 Months Ended		12 Months Ended
	May 15, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Other disclosures
Compensation expense		$ 130,000	$ 60,000.00
Purchaseable stock		23,452,117		19,795,053
Contra-revenue related to warrants granted to licensee		$ 10,000
Warrants
Number of Other than Options
Outstanding and exercisable, beginning balance (in shares)		1,116,065
Issued (in shares)		182,952
Exercised (in shares)		0
Expired/Forfeited (in shares)		0
Outstanding, ending balance (in shares)		1,299,017		1,116,065
Exercisable (in shares)		116,065
Weighted Average Exercise Price
Outstanding and exercisable, beginning balance (in dollars per share)		$ 1.67
Issued (in dollars per share)		0.81
Exercised (in dollars per share)		0
Expired/Forfeited (in dollars per share)		0
Outstanding, ending balance (in dollars per share)		1.55		$ 1.67
Exercisable, ending balance (in dollars per share)		$ 3.15
Weighted Average Remaining Contractual Life (in Years), Outstanding		7 years 9 months		8 years 5 months 15 days
Weighted Average Contractual Life (in Years), Exercisable		3 months 18 days
Aggregate Intrinsic Value, Outstanding		$ 0		$ 0
Aggregate Intrinsic Value, Exercisable		0
Other disclosures
Compensation expense		$ 0	$ 0
Warrants | Halston License
Other disclosures
Warrant term	10 years
Purchaseable stock	1,000,000
Warrants outstanding, exercise price (in dollars per share)	$ 1.50
Contra-revenue related to warrants granted to licensee	$ 10,000.00
Number of shares vested	0

Earnings (Loss) Per Share - Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Earnings (Loss) Per Share [Abstract]
Net loss attributable to Xcel Brands, Inc. stockholders	$ (6,294)	$ (5,643)
Basic weighted average number of shares outstanding	20,374,920	19,633,194
Diluted weighted average number of shares outstanding	20,374,920	19,633,194
Basic net loss per share	$ (0.31)	$ (0.29)
Diluted net loss per share	$ (0.31)	$ (0.29)

Earnings (Loss) Per Share - Anti-dilutive Securities Excluded (Details) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive securities	6,188,057	5,484,845
Employee Stock Option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive securities	4,889,040	5,368,780
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Dilutive securities	1,299,017	116,065

Income Taxes (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate	0.00%	0.00%
Income tax (benefit) provision	$ 0	$ 0

Related Party Transactions - IM Topco, LLC & License Agreement (Details) - USD ($)	1 Months Ended	3 Months Ended
	Nov. 30, 2023	Mar. 31, 2024	Mar. 31, 2023	May 31, 2022
Asset Purchase Agreement
Payments for Royalties		$ 0
Accrued Royalties		375,000
IM Topco [Member] | Services Agreement
Asset Purchase Agreement
Due from related party				$ 300,000
Reduction in service fees	$ 600,000
Revenue from services provided		$ 37,500	$ 75,000
IM Topco [Member] | License Agreement
Asset Purchase Agreement
Royalty guarantees			$ 60,000	$ 400,000
Additional royalty payments	$ 450,000

Related Party Transactions - Financing Transactions (Details) - USD ($) $ / shares in Units, $ in Millions	Mar. 14, 2024	Mar. 31, 2024	Mar. 19, 2024	Mar. 15, 2024	Dec. 31, 2023
Asset Purchase Agreement
Purchaseable stock		23,452,117			19,795,053
Common stock issued		23,452,117			19,795,053
Public Offering and Private Placement
Asset Purchase Agreement
Common stock issued				3,579,064
Public Offering
Asset Purchase Agreement
Purchaseable stock			3,284,422	3,284,422
Common stock price			$ 0.65	$ 0.65
Share price			$ 0.65
Public Offering | Chief Executive Officer
Asset Purchase Agreement
Common stock issued			146,250
Public Offering | Director
Asset Purchase Agreement
Common stock issued			146,250
Public Offering | Executive Vice President [Member]
Asset Purchase Agreement
Common stock issued			32,500
Private Placement
Asset Purchase Agreement
Common stock price	$ 0.98
Net proceeds from the sale of private placement shares	$ 0.3
Private Placement | Agreements [Member]
Asset Purchase Agreement
Common stock issued	294,642
Private Placement | Chief Executive Officer
Asset Purchase Agreement
Common stock issued	132,589
Private Placement | Director
Asset Purchase Agreement
Common stock issued	132,589
Private Placement | Executive Vice President [Member]
Asset Purchase Agreement
Common stock issued	29,464

Commitments and Contingencies - Narrative (Details)				3 Months Ended	12 Months Ended
	Feb. 16, 2024 USD ($)	May 31, 2022 USD ($) item	Apr. 01, 2021 USD ($)	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Commitments and Contingencies
Lease expiration date				Oct. 30, 2027
Contingent obligation				$ 5,432,000	$ 5,432,000
Additional consideration is payable to the seller	$ 963,642
Earn out payment	$ 241,000
Isaac Mizrahi sale transaction with IM Topco | Disposed of by Sale
Commitments and Contingencies
Number of consecutive quarters for royalty payable term | item		4
Royalty payable term		3 years
Isaac Mizrahi sale transaction with IM Topco | Disposed of by Sale | Maximum
Commitments and Contingencies
Royalty guarantees		$ 13,300,000
Adjustments to purchase price payable		$ 16,000,000
Lori Goldstein Brand
Commitments and Contingencies
Contingent consideration			$ 12,500,000
Contingent obligation					5,400,000
Royalties earned				6 years
Contingent obligation (Lori Goldstein Earn-Out)			$ 6,600,000	$ 300,000	200,000
Additional consideration is payable to the seller				$ 700,000	$ 1,000,000.0	$ 200,000

Subsequent Events (Details) - USD ($)	Apr. 12, 2024	May 31, 2022	Apr. 30, 2024
Business Venture Agreement
Subsequent Event [Line Items]
Net cash flow distributable to members (in percent)		100.00%
Net cash flow distributable to members		$ 1,316,200
WHP | Business Venture Agreement
Subsequent Event [Line Items]
Net cash flow distributable to members (in percent)		100.00%
Net cash flow distributable to members		$ 8,852,000
Subsequent Events | IM Topco, LLC
Subsequent Event [Line Items]
Ownership interest	30.00%
Subsequent Events | IM Topco, LLC | If Royalties Receivable Less Than Specified Amount
Subsequent Event [Line Items]
Ownership interest	17.50%
Subsequent Events | IM Topco, LLC | Twelve-month period ending March 31, 2025
Subsequent Event [Line Items]
Threshold royalties below which the equity interest would be transferable	$ 13,500,000
Subsequent Events | IM Topco, LLC | Year ending December 31, 2025
Subsequent Event [Line Items]
Threshold royalties below which the equity interest would be transferable	$ 18,000,000.0
Subsequent Events | IM Topco, LLC | WHP
Subsequent Event [Line Items]
Ownership interest	70.00%
Equity interests transferred			$ 100,000
Subsequent Events | IM Topco, LLC | WHP | Business Venture Agreement
Subsequent Event [Line Items]
Net cash flow distributable to members (in percent)	50.00%
Net cash flow distributable to members	$ 1,000,000.0
Subsequent Events | IM Topco, LLC | WHP | If Royalties Receivable Less Than Specified Amount
Subsequent Event [Line Items]
Ownership equity transferable	12.50%
Ownership interest	82.50%
Certain payments owed	$ 375,000

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (6,294)	$ (5,643)

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

---